LPBI Group News
6/16/2019
eProceeding 2019 Koch Institute Symposium – 18th Annual Cancer Research Symposium – Machine Learning and Cancer, June 14, 2019, 8:00 AM-5:00 PM ET MIT Kresge Auditorium, 48 Massachusetts Ave, Cambridge, MA
Tweets, Pictures and Retweets at 18th Annual Cancer Research Symposium – Machine Learning and Cancer, June 14, 2019, MIT by @pharma_BI and @AVIVA1950 for #KIsymposium PharmaceuticalIntelligence.com and Social Media
6/15/2019
My week on Twitter 
: 5 Mentions, 2.59K Mention Reach, 37 Likes, 41 Retweets, 186K Retweet Reach. See yours with https://sumall.com/performancetweet?utm_source=twitter&utm_medium=publishing&utm_campaign=performance_tweet&utm_content=text_and_media&utm_term=982cd4ccfc5b4b8fbd4f691a …
6/15/2019
Thanks to Gail Thornton for arranging the Audio Podcast: On Air Now – 3D BioPrinting
Medical 3D BioPrinting – The Revolution in Medicine
Technologies for Patient-centered Medicine:
https://www.amazon.com/dp/B078QVDV2W
BioPrinting 2019 FINAL
From: Partners in Health and Biz Radio Show
https://www.spreaker.com/user/pihandbiz/bioprinting-2019-final
6/14/2019
Gail wrote on 6/10/2019
- The audio podcast on the 3D-Bioprinting e-book will air this Saturday, June 15 @10am. I will send you the link once I receive it from Partners in Health & Biz.
And then we can write a short article and post it to the LPBI Group online journal.
6/10/2019
WHAT ARE LPBI Group’s NEEDS in June 2019
Aviva’s BOLD VISION on June 11, 2019
Task 1: Artificial Intelligence in Medicine
– Weekly engagement
Majority of healthcare organizations are testing out AI
June 05, 2019 | Amy Baxter | Connected Care
https://www.aiin.healthcare/topics/connected-
Task 2: Promotion of BioMed e-Series to Med Schools
– Monthly engagement
Task 3: Going DIRECT for finding an M&A partner
– Quarterly engagement
Team Members’ Tasks Assignment
6/10/2019
Books in use at US Medical Schools:
6/2019 – Susan B. Klein, PhD, Department of Physics, Indiana University, Bloomington
(another Berkeley alum) will be using for her forthcoming book on Radiation Biology, World Scientific Press, 2023, articles from the following three LPBI Group’s BioMed e-Series:
- Cardiovascular Diseases, Volume Three: Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics.
On Amazon.com since 11/29/2015
http://www.amazon.com/dp/B018PNHJ84
- Volume 1: Genomics Orientations for Personalized Medicine. On Amazon.com since 11/23/2015
http://www.amazon.com/dp/B018DHBUO6
- Volume 1: Cancer Biology & Genomics for Disease Diagnosis. On Amazon.com since 8/11/2015
http://www.amazon.com/dp/B013RVYR2K
- Volume 2: Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery (Series C Book 2). On Amazon.com since 5/18/2017
http://www.amazon.com/dp/B071VQ6YYK
- 250 Medical Schools in the US
- Europe
In 2019, Class II, e-Books are in Use in Medical Schools in the State of Pennsylvania for curriculum development:
Series A: Volume 3 – Epigenetics, Genetics and Genomics [Jefferson Medical School, Philadelphia]
Series B: Volume 1 – Genomics & Personalized Medicine [Temple University, Philadelphia]
Series C: Volume 1,2 – Cancer [Temple University, Philadelphia]
Series E: Volume 1 – Voices of Patients [Jefferson Medical School, Philadelphia]
Case Western Medical School – need to follow up on a contact from the Conference that I covered at Harvard Law School on Genomics and Ethics on 5/17/2019.
@PharmaceuticalIntelligence.com Journal: Article Publication by LPBI Group’s FIT Members, January 2019 – June 2019
Reporter: Aviva Lev-Ari, PhD, RN
| Curator’s Name | 1/1/2019 – 6/30/2019 |
7/1/2019 – 12/31/2019 |
| Dr. Sudipta Saha |
20 |
|
| Dr. Stephen J. Williams | 37 | |
| Dr. Irina Robu |
19 |
|
| Dr. Dror Nir |
4 |
|
| Gail S. Thornton |
7 |
|
| Amnon Denzig |
1 |
|
| Rick Mandhal |
1 |
|
| Dr. Aviva Lev-Ari |
94 [51.37%] |
|
| Total |
183 |
| 1/22/2019 | e-Readers | # Articles | Scientific Comments | Research Categories |
| LPBI Group | 1,563,240 | 5,469 | 7,308 | 666 |
| Aviva Lev-Ari, PhD, RN | 393,545 | 3,245 |
| 6/10/2019 | e-Readers | # Articles inclusion in Article Scoring System
for Journal Valuation |
Scientific Comments | Research Categories |
| LPBI Group | 1,632,642 | 5,621
+all are in a DB with e-Readers per article +all articles views in each e-Book will be completed in June’19 +Length per article work in progress
|
7,346 | 682 |
| Aviva Lev-Ari, PhD, RN | 409,063 | 3,303 |
Top Authors for all days ending 2019-06-10 (Summarized)
All Time
Managing social media – AgoraPulse.com
under consideration
Schedule your content, get reports, and engage followers with one simple tool.
- Engagement & Monitoring
- Priority Inbox
- Advanced Sync
- Inbox Assistant
- Inbox Filters
- Unlimited Listening Searches
- Assign Inbox Items
- Ad Comments Monitoring
- Internal Notes
- Publishing
- Unlimited Scheduled Posts
- Unlimited Queued Posts
- Queue Categories
- Assign & Approve Posts
- Chrome Extension
- Bulk Scheduling
- Bit.ly Integration
- UTM Parameters
- Label Content
- Reporting
- Unlimited Report Exports
- Facebook ROI Calculator
- Facebook Competitor Analysis
- Data Retention
- Social CRM
- Customer History
- Custom Notes
- Custom Labels
- Automated Badges & Ranking
- Other Benefits
- Team Workflow
- Mobile App
- 24/7 Support
- Workshop
- Account Manager
-
- 10 social profiles, 3 users
- Add-on Profile US$12/mo
- Add-on User US$39/mo
- 300 Active Ads per profile
- 6 Months
- Email Support
US$239
-
- 40 social profiles, 12 users
- Add-on Profile US$6/mo
- Add-on User US$39/mo
- 1000 Active Ads per profile
- 24 Months
- Priority Email & Chat Support
- Onboarding Workshop
US$459
-
- 70 social profiles, 20 users
- Add-on Profile US$4/mo
- Add-on User US$15/mo
- 2000 Active Ads per profile
- 24 Months
- Priority Email, Chat & Phone Support
- Custom Training
- Dedicated Account Manager
Real Time Coverage of BIO 2019 International Convention, June 3-6, 2019 Philadelphia Convention Center; Philadelphia PA
Reporter: Stephen J. Williams, PhD @StephenJWillia2
eProceedings for BIO 2019 International Convention, June 3-6, 2019 Philadelphia Convention Center; Philadelphia PA, Real Time Coverage by Stephen J. Williams, PhD @StephenJWillia2
5/29/2019
From: Harvard Medical School <pgme@hms.harvard.edu>
Reply-To: <pgme@hms.harvard.edu>
Date: Wednesday, May 29, 2019 at 1:16 PM
To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>
Subject: Registration Pending Approval – Media & Medicine: How to Tell Stories That Make A Difference (Media & Med) 2020
Wednesday, May 29, 2019
Dear Aviva Lev-Ari,
Thank you for submitting your application for the Media & Medicine: How to Tell Stories That Make A Difference (Media & Med) 2020. Your application has been received and is under review. You will be notified of your application status within four weeks of submission.
Please note that only completed applications will be reviewed for admission.
Click here to view your application details.
You will be asked to enter your confirmation number: DVNQ382RYR4
Please add pgme@hms.harvard.edu to your safe senders or contacts list to ensure you receive updates on your application and program announcements. Do not hesitate to contact us if you have any questions.
Thank you for your application to Media & Med Program.
Sincerely,
The Admissions Team
Postgraduate Medical Education
Harvard Medical School
5/28/2019
Most recent five articles on Schizophrenia in pharmaceuticalintelligence.com
- Molecular basis for schizophrenia
Larry H. Bernstein, mD, FCAP, Curator
https://pharmaceuticalintelligence.com/2016/05/08/molecular-basis-for-schizophrenia/
- Schizophrenia, broken-links
Larry H. Bernstein, MD, FCAP, Curator
https://pharmaceuticalintelligence.com/2016/04/05/schizophrenia-broken-links/
- Schizophrenia genomics
Larry H. Bernstein, MD, FCAP, Curator
https://pharmaceuticalintelligence.com/2016/03/15/schizophrenia-genomics/
- Imaging Schizophrenia Brain
Larry H. Bernstein, MD, FCAP, Curator
https://pharmaceuticalintelligence.com/2015/10/27/schizophrenia-brain/
- Outstanding Achievement in Schizophrenia Research
Larry H. Bernstein, MD, FCAP, Curator
https://pharmaceuticalintelligence.com/2015/09/06/outstanding-achievement-in-schizophrenia-research/
5/24/2019
Resources on Artificial Intelligence in Health Care and in Medicine: Articles of Note at PharmaceuticalIntelligence.com @AVIVA1950 @pharma_BI
https://www.linkedin.com/pulse/resources-artificial-intelligence-health-care-note-lev-ari-phd-rn/
5/22/2019
Leaders in Pharmaceutical Business Intelligence Group (“LPBI Group”) is an electronic scientific publishing venture that has developed proprietary, advanced platform architecture methodologies and business models, i.e., combination drug therapies, conceptual drug designs and forecasting demand models. Through the creation of original scientific content using a methodology of curation of scientific findings that they have developed and implemented since 4/2012, LPBI Group became a powerhouse for curation of scientific findings and methodology development for e-scientific publishing, growing its journal archive to +5,500 articles.
The Group has three interrelated healthcare content products: an open-access online scientific journal; a series of 16 BioMed e-books; and real-time coverage of BioMed scientific and medical conferences. Through these transformative products, the Group effectively meets and exceeds the information needs of researchers, scientists and industry pharmaceutical and biotechnology executives by offering real-time and currently available medical and scientific information on any biomedical subject (700 categories). Please visit us at http://pharmaceuticalintelligence.com and on Twitter (@pharma_BI, @Aviva1950).
5/21/2019
Updated Profile of Leaders in Pharmaceutical Business Intelligence (LPBI) Group
Expertise of our Team members includes functional areas of the e-Scientific Publishing segment https://lnkd.in/ejXnvUN
• Our IP is most valuable for several industrial sectors and economic segment as described https://lnkd.in/dNHYWGH
• We offer several Media Distribution Channels for Contents and Events as described https://lnkd.in/dnHVBKv
• We welcome partnerships and inter-organizational interfaces for collaboration purposes. We are seeking Joint Ventures, M&A and other structures to leverage our IP and the deep expertise of our Team Contact us
5/20/2019
Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Newton, MA is a venture launched on April 2012.
LPBI Group is a start up that developed content in the following domains:
Our DOMAINS in Scientific Media
I. Pharmaceutical: Biologics, Small Molecules, Diagnostics
II. Life Sciences: Genomics and Cancer Biology
III. Patient-centered Medicine: Focus on #1: Cardiovascular, #2: Cancer, #3: Physiology Metabolomics, Immunology
IV. Biomedicine, BioTech, and MedTech (Medical Devices)
V. HealthCare: Patient-centered Medicine and Personalized/Precision Medicine
OUR three health care Intellectual Property (IP) Content Asset Classes:
- IP Asset Class I: Corpus of 5,600 Scientific Articles in the Open Access Journal @PharmaceuticalIntelligence.com
- IP Asset Class II: Corpus of 16 Volumes in LPBI Group’s BioMed e-Series
- IP Asset Class III: Corpus of +60 Conference eProceedings
https://pharmaceuticalintelligence.com/press-coverage/
5/17/2019
LIVE 2019 Petrie-Flom Center Annual Conference: Consuming Genetics: Ethical and Legal Considerations of New Technologies, Friday, May 17, 2019 from 8:00 AM to 5:00 PM EDT
Tweets and Re-Tweets by @Pharma_BI and @AVIVA1950 at 2019 Petrie-Flom Center Annual Conference: Consuming Genetics: Ethical and Legal Considerations of New Technologies, Friday, May 17, 2019 from 8:00 AM to 5:00 PM EDT @Harvard_Law
5/12/2019
LIVE 13th Annual BioPharma & Healthcare Summit, Thursday, May 9, 2019, Marriott Hotel, Cambridge, MA
Tweets and Retweets by @AVIVA1950 and by @pharma_BI for @USAIC and #USAIC2019 at the 13th Annual BioPharma & Healthcare Summit, Thursday, May 9, 2019, Marriott Hotel, Cambridge, MA
5/6/2019
Dr. Lev-Ari was solicited by MIT Inclusive Innovation Challenge (MIT IIC) to register for 2019 applicant pool of entrepreneurs developing digital technologies for the workplace.
The IIC is the flagship program of the MIT Initiative on the Digital Economy, annually celebrating entrepreneurs who are using technology to create innovative solutions to global challenges. Global Winners will receive the award at the Global Grand Prize Gala at MIT. In the last three years, the IIC has awarded 100 organizations around the world. View past winners.
https://challenge.mitinclusiveinnovation.com/applications/2900/printable
5/2/2019
#usaic19 @pharma_BI @AVIVA1950 13th Annual BioPharma & Healthcare Summit, Thursday, May 9, 2019, Marriott Hotel, Cambridge, MA https://pharmaceuticalintelligence.com/2019/04/30/13th-annual-biopharma-healthcare-summit-thursday-may-9-2019/ … via @Pharma_BI
5/1/2019
@Pharma_BI @AVIVA1950 Make this World a better place, students you are the FUTURE. 20 final teams finalists to pitch in 15 seconds #human #health #Lab to #bedside 5 finalist Flotherm, GC therapeutics, Kinnos, Lima BioSciences, longsleeve,
-
You Retweeted
@Harvard#innovationLab 8th Annual President’s Innovation Challenge Award Ceremony begins Change the World @jodigoldstein#Leaders#culture#innovation#celebrate#failure $1.5Billion raised 54% female applicants 50% applicant of color ingenuity Awards @Pharma_BI0:3318 views -
You Retweeted
-
You Retweeted
@Harvard 2019 President’s Innovation Challenge Showcase & Award Ceremony 4 categories:#HealthLifeScience#socialImpact#OpenTrack#LaunchLabX@AVIVA1950 @Pharma_BI
-
You Retweeted
@Pharma_BI@AVIVA1950#PIC2019#SocialImpact category Coding it Forward, JustFix is the Winner, Generus, MDaas Global MRI to Africa, New Teachers Thriving (GDE),
-
You Retweeted
#PIC2019 @Pharma_BI@AVIVA1950#OpenTrack LeverEdge, MyToolBox- is the winner, http://Porto.ai , ReThink- Grand Prize, Voodles,
-
You Retweeted
#PIC2019 @Pharma_BI@AVIVA1950 five teams solutions for CHANGING THE WORLD, Jamber-Grand Prize winner, Legacy, Nilus, Sophia -the winner, Zubale,
-
You Retweeted
#PIC2019 INGINUITY Award, 300 applications 200 advisors. Awards for ingenuity: Three ideas $2500 increase Teachers, GES, $2500 child care edu, GSB, $5,000 Steel manufacturing waste silicon instead of CO2. @Pharma_BI@AVIVA1950
4/30/2019
-
@MGHCancerCenter#AI to read memo grams for prediction of future cancer age family history prior procedure 42% density out 212K 8 have dense deep neural network model image vs model image +RF DL white vs non white high Risk Density bias free @Pharma_BI@AVIVA1950
-
@MIT @kochinstitute @Pharma_BI@AVIVA1950#breastcancer o accurate tools for early detection or predicts future disease progression or remission 6 out of 200,000 images will are cancer variation of image interpretation breast density for notification
4/25/2019
Tweets by @pharma_Bi and @AVIVA1950 at #GenMed2019 on Translating Genetics into Medicine, April 25, 2019, 8:30 AM – 6:00 PM, The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York
LIVE – Translating Genetics into Medicine, April 25, 2019, 8:30 AM – 6:00 PM, The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York
Real Time Press Coverage: Aviva Lev-Ari, PhD, RN
4/22/2019
|
@AVIVA1950 SUMALL Weekly Digest
|
04/07/2019 – 04/13/2019 #WMIF19 04/08/2019 – 04/10/2019
|
| Likes |
125 |
| Followers |
391 |
| Friends |
1.5K |
| Mentions Reach |
23.7K |
| Mentions |
14 |
| Replies |
0 |
| Retweet Reach |
130.4K |
| Retweets |
66 |
| Tweets |
154 |
SOURCE
From: SumAll <sumall@sumall.com>
Date: Monday, April 22, 2019 at 4:35 AM
To: “<Aviva Lev-Ari>”, <PhD>, Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>
Subject: My Weekly Digest: Week of Apr 14, 2019
4/22/2019
We met a MILESTONE on 4/19/2019 – we sent out to NY two documents of great significance.
The CHARTER during an Interim Period – AVIVA’s VISION POST 4/19/2019
a. Create strategic directions for current LPBI Group IP Asset Classes: I, II, III
b. Lay out the foundation for LPBI Group’s newly defined pipelines in Document #2 – our future legacy following the 16th e-Book completion in 2019.
b.1 Potential emergence of e-Book #17
—->>>> Major discovery in Cell Journal @UCSF on B cells impact on immunology and vaccine design – let to a new project I launched yesterday:
- MWF to get Full Document
- Dr. Saha to write new curation
- Dr. Williams to comb the archive on B Cells research
- Dr. Irina to Update 6 existing B cell articles in the Journal with URL of Dr. Saha’s new curation
- Dr. Irina to write impact of Dr. Saha’s curation content on Vaccine Design
- Dr. Larry to review all of the above
- If Dr. Williams is fetching a pool of existing B Cell articles in our Journal to be >60, THEN
- Aviva to launch Series D, Volume 4 on B Cell in Vaccine Design
Series D, Volume 4: Editors: Saha, Williams, Irina, Aviva
THIS WILL BE THE FIRST BOOK IN EXISTENCE on the 2019 discovery @UCSF on new roles for B cells beyond production of antibodies
c. Gradually build capabilities of LPBI Group’s Specialty in Consulting using IP Asset Class IV: Business Methods applIed in Biotech for Biotech and Pharma, where Business Side and our Scientists (newly, to be recruited) work jointly on Client assignments using our IP Asset Classes: I, II, III, IV.
—>>> Business side get engagements —>>> Scientists side develop and deliver on engagement
ALL,
Till we learn from IB about
—->>>>> “are we a NEW Client of xxxx, Investment Banker, NY: yes or no”
- We may get second round of RFI from the IB before that decision is made
WE shift focus to OTHER activities:
1. Gail’s Marketing Communications initiatives:
1.1 Podcasts on our e-Books:
– 3D BioPrinting, May 3
– Voices of Patients, date TBD
1.2 Newsletter — I update LPBI Group News, Gail uses this content and other content
2. WE focus all FIT Scientists on @UCSF Discovery on B Cells, as above
3. WE work to publish Genomics Volume 2 in 2019.
4. Amnon and Rick continue to work on Business Development concepts – Plan B
5. KICK OFF SKYPE SESSION ALL FIT MEMBERS in May 2019 – Date/Time: TBD, Organizer: Irina
4/20/2019
CONGRATULATIONS to Amnon, Gail and Rick for bringing to completion thie OWN initiative to create a Business Plan for LPBI Group.
Amnon:
I am happy that you demonstrated to me your thought process. You were given a difficult challenge, taking the ball and running with it, is a very high bar to jump, you did it beautifully on several levels:
1. You challenged yourself
2. You produced artifacts that I could use “as is” into my own work on Document #2 – key 🔑 for me to extend my capabilities
3. Now, I know HOW to activate you for high qualitative outcomes in concept formation
THANKS to Gail and Rick:
4. You on your own, with my suggestion, activated Gail and Rick to produce significant artifacts
5. Together, the three produced the first version of the LPBI Group’s Business Plan
6. It had the originality I am seeking when I say, “teach me something new.” Because, I always need more building blocks to generate new IP
7. Taking it all together, I gained the confidence that Business Side on LPBI Group’s FIT can and will continue to build IP Asset Class IV: Business Methods which has few potentials
4/14/2019
The #WMIF19 Influencers via @symplur‘s #Healthcare Hashtags http://bit.ly/WMIF19 – By Mentions and By Tweets Ranked #4: @pharma_BI and #2: @AVIVA1950, respectively. Ranked #3 via NodeXL Betweenness Centrality http://bit.ly/2KB6cPN
4/13/2019
Twitter Data for LPBI Group’s Founder’s Twitter handle @AVIVA1950 was updated
On 2/24/2019 — Tweets 8,060 Following 1,412 Followers 359 Likes 2,752
On 4/13/2019 — Tweets 9,018 Following 1,461 Followers 390 Likes 3,654
- In 48 days # Follower increases from 359 to 390 – Growth rate of 8%
- Three new “I” Followers were selected to be added in 48 days since 4/24/2019 = 25,667 Followers of Followers
- Eight new “P” Followers were selected to be added in 48 days since 4/24/2019 = 425,971 Followers of Followers
- Total “I” + “P” on 2/24/2019 was 2,580,051
- Total “I” + “P” on 4/13/2019 was 3,031,689
- Growth Rate of Followers’ Followers 17.5% in 48 days
Thus, on 4/13/2019 the Followers DATA in the Excerpt is base on 117 on 2/24/2019 plus 11 [2 and 3, above] = 128 Followers
4/13/2019
@symplur‘s #Healthcare Hashtags – Twitter Analytics published for http://bit.ly/WMIF19
- [Top 10 by Mentions – @pharma_BI = 4 with 181 mentions]
- [Top 10 by Tweets @AVIVA1950 = 2 with 229 Tweets (N = 152 Direct messages)]
Pinned Tweet
More
As World #Medical #Innovation Forum comes to a close, here are TOP #WMIF19 #influencers via @symplur‘s #Healthcare Hashtags
to organizers for a stellar event & to all on #MedTwitter for a robust conversation! #AI @PHSInnovation @ChrisMarkCOBURN
Partners HealthCare, GE Healthcare, Brigham Digital Innovation Hub and 6 others
3 replies
12 retweets
15 likes
Direct message
4/11/2019
Top 3 Ranked by Betweenness Centrality in Top 10 Influencers #WMIF19 @phsinnovation @evankirstel @aviva1950 –Tweeter Analytics by NodeXL http://bit.ly/2KB6cPN for #WMIF19 by @PHSInnovation at World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 8-10, 2019
Tweets, ReTweets and Likes by @AVIVA1950 and by @pharma_BI using @PHSInnovation and #WMIF19 during Day One, Two and Three of World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 8-10, 2019
LIVE Day One – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Westin Copley Place, Boston, MA USA, Monday, April 8, 2019
LIVE Day Two – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 9, 2019
LIVE Day Three – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 10, 2019
4/2/2019
Total 2,241,388
- [Media 375,606]
Institutions (I) – Total 1,786,443
- [Media Companies 341,716]
Individuals (P) – Total 430,725
- [Media Individuals 13,390]
LPBI Group is mostly honored to have its Founder’s Twitter handle @AVIVA1950 been followed by top Scientific research organization who are leaders in e-Scientific content production, chiefly,
| Technion Israel | @TechnionLive | 47,800 followers | |
| Broad Institute | @MIT @HARVARD @broadinstitute | 46,000 followers | |
See all @AVIVA1950 that we declared as “mostly honored to be followed by”
- Mostly HONORED to be followed by [from an Excerpt of 117 Followers of the Twitter Account @AVIVA1950 from the List of 359 Followers] by the Number of their Followers on 2/24/2019
3/29/2019
TWEETS and Retweets by @pharma_BI and @AVIVA1950 on Day One and Day Two: 2019 MassBio Annual Meeting, State of Possible Conference, Sonesta Hotel, Cambridge, March 27, 2019
LIVE Day Two: 2019 MassBio Annual Meeting, State of Possible Conference, Sonesta Hotel, Cambridge, March 28, 2019
LIVE Day One: 2019 MassBio Annual Meeting, State of Possible Conference, Sonesta Hotel, Cambridge, March 27, 2019
3/21/2019
Announcement
Amnon Danzig, FIT member, our Strategic Thinker, will be presenting a 20 minute Conference Presentation at the Second Global Conference on Creating Value on May 14-15, 2019 at Fordham University’s Gabelli School of Business at 140 West 62nd Street in New York City.
The details of the conference program will be listed on the conference website soon. For updates, please check
http://www.creatingvalue.co/creating-value-conference-programme/
SOURCE
From: Global Creating Value 2019 <creatingvalue2019@fordham.edu>
Date: Wed, Mar 20, 2019, 15:32
Subject: Second Global Conference on Creating Value – Presenter Information
To: Fordham Creatingvalue2019 <creatingvalue2019@fordham.edu>
Sertan Kabadayi, PhD
Conference Co-chair
Area Chair – Marketing
Professor of Marketing
Gabelli School of Business
Fordham University- Lincoln Center
140 West 62nd Street, Suite 446
New York, NY, 10023
Phone: 212.636.7804
Email: Kabadayi@Fordham.edu
3/21/2019
Announcement
LPBI Group will be covering in Real Time 2019 18th BioIT Conference on 4/16/2019 – 4/18/2019 at Seaport World Trade Center, Boston, MA.
Aviva Lev-Ari, PhD, RN
will be in attendance in Real Time generating the conference e-Proceedings and on Social Media using
#BioIT2019
and
pharmaceuticalintelligence.com
Official LPBI Twitter account
Aviva Lev-Ari, PhD, RN Private Twitter account
SOURCE
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
3/12/2019
Our WEBSITE is NOW on a Business Site Plan – What does that mean
We need to
- CUSTOMIZATION of the Website
- e-Mail @pharmaceuticalintelligence.com
Our WEBSITE is NOW on a Business Site Plan – What does that mean
powerful tools and support included in enhanced WordPress.com plans that can help fast-track the success of your site, whatever your goals may be.
With an upgraded site you can:
- Impress your friends with your very own domain name (instead of having WordPress.com in your URL).
- Quickly resolve any roadblocks by connecting with our all-star customer service team through live-chat support.
- Bring your design vision to life with over 100 professionally designed templates to choose from.
- Gain complete control of your site when you unlock custom CSS capabilities (Premium, Business, and eCommerce plans).
- Build your community, connect with customers, or grow your business with enhanced marketing and eCommerce tools.
Hi 2012pharmaceutical,
We’re excited that you purchased the Business plan on pharmaceuticalintelligence.com. It’s the perfect way to supercharge your site with advanced SEO tools, Google Analytics, free Premium themes, and more.
As part of your Business plan, you can schedule a free, personalized concierge session with one of our Happiness Engineers for real-time, one-on-one help. Just choose a time that works for you in the link below:
|
We’ll answer any questions you have, and we’ll show you some of the awesome features that come with your Business plan. You can also reply to this email with any questions, or reach us via live chat at https://wordpress.com/help/contact.
Professional email and so much more
Make the right first impression and promote your website every time you send an email with an account @pharmaceuticalintelligence.com.
|
We’ve teamed up with Google Cloud to offer you professional email and a suite of productivity tools, including:
| Gmail for @pharmaceuticalintelligence.com
Professional ad-free email that works with most email clients. |
|
| Keep all your files secure Get 30GB of storage for all your files, and access them from your phone, tablet, or computer. |
|
| Docs, spreadsheets and forms
Create and edit documents at the same time as others to get your work done faster. |
|
| Connect with your team Use text chats, voice calls, or video calls, with built in screen sharing. |
Don’t wait — get the first two months free when you add G Suite to your site today.
|
| The WordPress.com Team |
|
|
|||||
|
3/12/2019
Covering this event in Real Time @pharma_BI @AVIVA1950
2019 Koch Institute Symposium – Machine Learning and Cancer, June 14, 2019, 8:00 AM-5:00 PM ET MIT Kresge Auditorium, 48 Massachusetts Ave, Cambridge, MA
3/2/2019
- Excerpt of 117 Followers of @AVIVA1950 (from the List of 359 Followers) by the Number of their Followers
-
Institutional Follower’s Followers = 1,354,885
-
Individual (person) Follower’s Followers =1,157,741
-
Number of Followers of @AVIVA1950 117 Followers –>>>>> Total 2,512,626
| HIGHEST HONOR to be followed by [From an Excerpt of 117 Followers of @AVIVA1950
(from the List of 359 Followers)] by the Number of their Followers |
Aviva Lev-Ari | Institutional Follower’s Followers = 150,617 Individual (person) Follower’s Followers = 345,000 Total = 495,617 | |
| Tweets
8,060 |
Following 1,412 | Followers 359 | Likes 2,752 |
| I = Institution P = Person RED = Highest HONOR to be Followed by | Follower Name | Twitter Handle | # of Followers |
| I | Technion Israel | @TechnionLive | 47,800 |
| I | Broad Institute | @MIT @HARVARD @broadinstitute | 46,000 |
| I | NFCR | @NFCR | 36,100 |
| I | Technion T³ | @TechnionT3 | 16,900 |
| I | BCM_CVRI | @BCM_CVRI | 2,249 |
| I | Partners Innovation | @PHSInnovation | 1,121 |
| I | Discovery on Target | @BostonDOT | 298 |
| I | PM Conference | PM Conference | 149 |
| Total of “I” | 150,617 | ||
| P | Dr Atanas G Atanasov | @_atanas_ | 107,000 |
| P | Eric Rodgers | @ericfrodgers |
87,700 |
| P | Dr. GP Pulipaka | @gp_pulipaka | 54,400 |
| P | Jan Oldenburg | @janoldenburg | 23,000 |
| P | BioInformant | @StemCellMarket | 21,300 |
| P | Dr. Stefan Gruenwald | @sgruenwald | 21,100 |
| P | John Belmont | @jwbelmon | 17,900 |
| P | Richard G. Lanzara | @rlanzara | 8,740 |
| P | Dr. Thomas Wilckens | @Thomas_Wilckens | 2,596 |
| P | Yuval Cohen | @CEOCorbus | 1,264 |
| Total “P” | 345,000 | ||
FIT Members Tweet to Followers of
@AVIVA1950
Tweet by Prof. Feldman
@broadinstitute @BioWorld @Biotech365 @pharma_BI @AVIVA1950 e-Journal pharmaceuticalintelligence.com ebooks https://lnkd.in/ekWGNqA Conference eProceedings DELIVERABLES & Social Media Analytics #RealTime #Press Looking forward to continued collaboration with @pharma_BI @AVIVA1950 supporting mutual efforts to promote #pharmanews #biotech #personalized #medicine #BioMedical #biotechnology #biopharma #science #research #pharmaceutical
Tweet by Dr. Williams
@TechnionLive @BostonDOT @PharmaVoice Looking forward to continued collaboration with @pharma_BI @AVIVA1950 supporting mutual efforts to promote #pharmanews #biotech #personalizedmedicine @StephenJWillia2
TWEET by Rick Mandahl
@NFCR @pharma_BI @AVIVA1950 e-Journal pharmaceuticalintelligence.com #cancer #biology #oncology #genomics #curations #realtime #cancer #researchers #globally #exploratory #discussions for #collaboration ebooks https://lnkd.in/ekWGNqA Conference eProceedings DELIVERABLES & Social Media Analytics
TWEET by Rick Mandahl
@PMC #Conference @harvardmed #patients #researchers #policymakers #health #pharma #execs #insurers – dedicated to improving #patient #outcomes #genomic #science #medicine #Collaborate #president @PMC #announcements #Realtime covered #Annual #Conference over 2 million LPBI followers #personalized #medicine to improve #Global #health @pharma_BI @AVIVA1950
TWEET by Rick Mandahl
@TechnionT3 #scientific #engineering #medical #research @Israel #innovation @global #progress @Boston @pharma_BI @AVIVA1950 e-Journal pharmaceuticalintelligence.com #cancer #biology #oncology #genomics #curations #realtime #cancer #researchers #globally #exploratory #discussions for #collaboration ebooks https://lnkd.in/ekWGNqA Conference eProceedings DELIVERABLES & Social Media Analytics over 1.6 million #global #eReaders including @TechnionT3 consider #strategy using @pharma_BI #IP for #progress of @TechnionT3 #dynamics. Let’s explore #joint #venture
Irina Robu, PhD
@broadinstitute @PHSInnovation @BostonDOT @StemCellMarket Looking forward to continuous partnership with @pharma_BI @AVIVA1950 supporting common efforts to promote #tissue engineering #biomaterials #stemcells #biotech #cell therapy #personalized #medicine @irirobu
TWEETS by AMNON to @AVIVA1950 Most Honored to be followed by Followers
@TechnionLive @amnon_danzig Two #strategic #structural #risks in @Scientific #Publishing for all #Scientists: #Information #Explosion, and the high rate of #Information #Obsolescence #Curation #Methodologies and #Data #Science serves as #mitigating #factors pharmaceuticalintelligence.com @pharma_BI curation methodology developed by @AVIVA1950 https://lnkd.in/eEyn69r is a #leader in the #complex #BioMed #field https://lnkd.in/ekWGNqA
@TechnionT3 @amnon_danzig Technology transfer requires the most relevant and up-to-date knowledge of all technologies pharmaceuticalintelligence.com @pharma_BI #curation #methodology developed by @AVIVA1950 https://lnkd.in/eEyn69r is a #leader in the #complex #BioMed #field https://lnkd.in/ekWGNqA #KnowledgeGap needs be narrowed for #successful #TechnologyTransfer
@PHSInnovation @amnon_danzig #invention or #innovation? Invention is a #technological #breakthrough while most #Innovation are born by #interdisciplinary cross #fertilization #Leaders in #curation #methodology developed by @AVIVA1950 https://lnkd.in/eEyn69r in #BioMed #fields https://lnkd.in/ekWGNqA pharmaceuticalintelligence.com @pharma_BI in #Medicine #LifeSciences #HealthCare #MedTech #BioTech #DrugDiscovery #PharmaceuticalIntelligence
2/18/2019
- Founder’s Role in the Development of Venture’s Factors of Content Production – Biographical Notes by Aviva Lev-Ari, PhD, RN, LPBI Group
- FIT Members Contribute to Opportunities Map
2/3/2019
LIST OF ASSETS
- Launched Open Access Online Scientific Journal @PharmaceuticalIntelligence.com, 4/2012
- Launched BioMed eSeries, 16-Volumes in Life Sciences and Medicine, 10/2012
Launched 6 Volumes #Cardiovascular e-Series, Bundled on Amazon for $515
Launched 10 Volumes in #Medicine #Genomics 1,2 #Cancer 1,2 #Immunology 1,2,3 #PrecisionMedicine 1,2,3,4
- Launched Real Time Press Coverage of Biotech Conferences, 3/2013
https://pharmaceuticalintelligence.com/press-coverage/
Part One: The Process of Real Time Coverage using Social Media
Part Two: List of BioTech Conferences 2013 to Present
Part Three: Conference eProceedings DELIVERABLES & Social Media Analytics
2/1/2019
TWITTER Handles
@pharmaceuticalintelligence.com
@pharma_BI
@AVIVA1950
https://lnkd.in/erfbayJ
1/31/2019
TWEETS by @pharma_BI and @AVIVA1950 at #IESYMPOSIUM – @kochinstitute 2019 #Immune #Engineering #Symposium, 1/28/2019 – 1/29/2019
Real Time Press Coverage: Aviva Lev-Ari, PhD, RN
1/29/2019
LIVE Day One – Koch Institute 2019 Immune Engineering Symposium, January 28, 2019, Kresge Auditorium, MIT
LIVE Day Two – Koch Institute 2019 Immune Engineering Symposium, January 29, 2019, Kresge Auditorium, MIT
1/26/2019
Team Tweets
#1 – ALL BioMed 16 Volumes
@Amazon BUNDLED @pharma_BI @AVIVA1950 https://lnkd.in/eEyn69r
6 Volumes #Cardiovascular for $515 https://lnkd.in/e6WkMgF
UNBUNDLED 10 Volumes in #Medicine https://lnkd.in/ekWGNqA
#Genomics 1,2 #Cancer 1,2 #Immunology 1,2,3 #PrecisionMedicine 1,2,3,4
#2 – Please Tweet – about Series E
@Amazon @pharma_BI BUNDLES for $274 #Patients #Voices #Precision #Medicine #Physiology #Genomics #Therapeutics #3D #BioPrinting: Series E: Volumes 1,2,3,4 by Editors: Larry H Bernstein @bernstein_h Gail Thornton @GailThornt Aviva Lev-Ari @AVIVA1950 https://lnkd.in/ekWGNqA
#3 – Please Tweet – about Series C
Amazon @pharma_BI BUNDLES for $175 Series C: #Cancer #Oncology
VOLUME 1 Cancer #Biology #Genomics http://www.amazon.com/dp/B013RVYR2K
VOLUME 2 #Therapies Genomics #Interventional #Immunotherapy #Nanotechnology in #Drug #Delivery http://www.amazon.com/dp/B071VQ6YYK
#4 – Please Tweet – about Series D
@Amazon @pharma_BI BUNDLES for $190 Series D: #Metabolomics #Immunology #Infectious #Diseases VOLUME 1 http://www.amazon.com/dp/B012BB0ZF0 VOLUME 2 & VOLUME 3 https://www.amazon.com/dp/B075CXHY1B
| 1/22/2019 | e-Readers | # Articles | Scientific Comments | Research Categories |
| LPBI Group | 1,563,240 | 5,469 | 7,308 | 666 |
| Aviva Lev-Ari, PhD, RN | 393,545 | 3,245 |
On 1/22/2019
#Updates to 2018 1,562,778 e-Readers @pharma_BI @AVIVA1950 https://lnkd.in/eEyn69r 393,431views
#Bundled #CVD #Diseases – 6 Volumes https://lnkd.in/e6WkMgF
#Bundled #Cancer 1,2 #immunology 1,2,3 #PrecisionMedicine 1,2,3,4 https://lnkd.in/ekWGNqA
On 1/20/2019 – 280 character Tweet
@Amazon.com BUNDLED for $515 @pharma_BI a Six-volume e-Series on #Cardiovascular #Diseases https://www.amazon.com/dp/B07MVF34ZC/ref=sr_1_1?s=digital-text #Genomics #Cancer #Metabolomics, #Immunology, #Infectious #Diseases #Patient #Voices #Precision #Medicine 4 Volumes https://www.amazon.com/s/ref=nb_sb_noss?url=search-alias%3Ddigital-text&field-keywords=Aviva+Lev-Ari&rh=n%3A133140011%2Ck%3AAviva+Lev-Ari @AVIVA1950
On 1/16/2019
BUNDLED FOR $515 BY AMAZON.COM INTO A SIX-VOLUME SERIES
SERIES A: Cardiovascular Diseases
https://www.amazon.com/dp/B07MVF34ZC/ref=sr_1_1?s=digital-text
2019
- Koch Institute 2019 Immune Engineering Symposium, January 28-29, 2019, Kresge Auditorium, MIT
Real Time Press Coverage: Aviva Lev-Ari, PhD, RN
https://calendar.mit.edu/event/immune_engineering_symposium_2019#.XBrIDc9Kgcg
- World Medical Innovation Forum, Partners Innovations, ARTIFICIAL INTELLIGENCE | APRIL 8–10, 2019 | Westin, BOSTON
Real Time Press Coverage: Aviva Lev-Ari, PhD, RN
https://worldmedicalinnovation.org/agenda-list/
- Translating Genetics into Medicine, April 25, 2019, 8:30 AM – 6:00 PM, The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York
Real Time Press Coverage: Aviva Lev-Ari, PhD, RN
- 13th Annual US-India BioPharma & Healthcare Summit, May 9, 2019, Marriott, Cambridge
Agenda Pending
Real Time Press Coverage: Aviva Lev-Ari, PhD, RN
- 2019 Petrie-Flom Center Annual Conference: Consuming Genetics: Ethical and Legal Considerations of New Technologies, May 17, 2019, Harvard Law School
Real Time Press Coverage: Aviva Lev-Ari, PhD, RN
http://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference
2018
On 12/23/2018 and on 12/24/2019 we published two e-Books in Series A: Cardiovascular Diseases
Pharmacological Agents in Treatment of Cardiovascular Diseases (Series A: Cardiovascular Diseases Book 5) Kindle Edition
by Justin D. Pearlman (Author), Larry H. Bernstein (Author),
Aviva Lev-Ari (Author)
On Amazon.com since 12/23/2018
Pharmacological Agents in Treatment of Cardiovascular Diseases (Series A: Cardiovascular Diseases Book 5)
Dec 23, 2018 | Kindle eBook
by Justin D. Pearlman and Larry H. Bernstein
Subscribers read for free.
$115.00$ 115 00 to buyKindle Edition
Get it TODAY, Dec 25
Sold by: Amazon Digital Services LLC
On Amazon.com
https://www.amazon.com/dp/B07MGSFDWR
https://www.amazon.com/dp/B07MGSFDWR
Electronic Table of Contents (eTOCs) for Volume 5 on LinkedIn
https://www.linkedin.com/pulse/pharmacological-agents-treatment-cardiovascular-book-aviva/
Detailed eTOCs
Interventional Cardiology for Disease Diagnosis and Cardiac Surgery for Condition Treatment (Series A: Cardiovascular Diseases Book 6) Kindle Edition
by Justin D. Pearlman (Author), Larry H. Bernstein (Author), Aviva Lev-Ari (Editor)
On Amazon.com since 12/24/2018
https://www.amazon.com/dp/B07MKHDBHF
Interventional Cardiology for Disease Diagnosis and Cardiac Surgery for Condition Treatment (Series A: Cardiovascular Diseases Book 6)
Dec 24, 2018 | Kindle eBook
by Justin D. Pearlman and Larry H. Bernstein
Subscribers read for free.
$100.00$ 100 00 to buyKindle Edition
Get it TODAY, Dec 25
Sold by: Amazon Digital Services LLC
https://www.amazon.com/dp/B07MKHDBHF
Electronic Table of Contents (eTOCs) for Volume 6 on LinkedIn
https://www.linkedin.com/pulse/interventional-cardiology-disease-diagnosis-cardiac-lev-ari-phd-rn/
Detailed eTOCs
@@@@
The Future of Precision Cancer Medicine, Inaugural Symposium, MIT Center for Precision Cancer Medicine, December 13, 2018, 8AM-6PM, 50 Memorial Drive, Cambridge, MA
New LINK, 12/4/2018:
2019 Strategic Marketing of LPBI Group’s Intellectual Property: Strength & Markets
- LIVE eProceedings Day One – The 14th Annual Personalized Medicine Conference: PREPARING FOR THE NEW POSSIBLE, November 14, 2018, HMS, Boston
Real Time Press Coverage: Aviva Lev-Ari, PhD, RN
- LIVE eProceedings Day Two – The 14th Annual Personalized Medicine Conference: The Business of Personalization, November 15, 2018, HMS, Boston
Real Time Coverage: Aviva Lev-Ari, PhD, RN
- Tweets by @pharma_BI and @AVIVA1950 for The 14th Annual Personalized Medicine Conference: The Business of Personalization, November 15, 2018, HMS, Boston
Tweeter and Real Time Conference Press Coverage: Aviva Lev-Ari, PhD, RN
LIVE 2018 The 21st Gabay Award to LORENZ STUDER, Memorial Sloan Kettering Cancer Center, contributions in stem cell biology and patient-specific, cell-based therapy
REAL TIME Reporter: Aviva Lev-Ari, PhD, RN
Nomination for 2018 Yidan Prize, recognition in the field of MEDICAL education: development of curation methodologies for scientific content – 2018 Nominee, Aviva Lev-Ari, PhD, RN
The History, Uses, and Future of the Nobel Prize, 1:00pm – 6:00pm, Thursday, October 4, 2018, Harvard Medical School – Did not attend due to conflict
Reporter in Real Time: Aviva Lev-Ari, PhD, RN
New Posts in 2018
17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM
-
IDEAS for Partnership and Funding to Advance our Mission —>> LPBI Group for the following purposes:
1 Revitalize the Drug Discovery concepts for R&D in conjunction with Dr. Nir
2 back-funding the IP value created for enabling near future transfer of ownership to a
not-for-profit organization or an NGO: I.e.,
– Mass Academy of Sciences,
– Hadassah Medical Sciences Department, HUJI, Jerusalem
– Technion Medical School
– UC, Berkeley’s Genomics Institute
– UC, Berkeley’s Public Health Department or
– UCSF
– Stanford Medicine Institutes
3. Finding for-profit potential acquirers: I.e.,
– Wolfram Kruwel, owner of UpToDate,
– KKR, holding company of WebMD
– eScientific Publishers: John Wiley, Pearson or Internationals in Japan, Germany,
- SYNOPSIS – 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM
- Original Tweets Re-Tweets and Likes by @pharma_BI and @AVIVA1950 at #kisymposium for 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM
- Survival Calls during Careers in the Digital Age
https://pharmaceuticalintelligence.com/2018/06/13/survival-calls-during-careers-in-the-digital-age/
- Reactions to Original Tweets by @Pharma_BI and by @AVIVA1950 from #BIO2018
- Re-Tweets and Likes by @Pharma_BI and by @AVIVA1950 from #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC
- Original Tweets by @Pharma_BI and by @AVIVA1950 from #BIO2018 @IAmBiotech @BIOConvention – BIO 2018, Boston, June 4-7, 2018, BCEC
- Thriving at the Survival Calls during Careers in the Digital Age – An AGE like Other, also known as, DIGITAL
- Reflections on a Four-phase Career: Aviva Lev-Ari, PhD, RN, March 2018
- Pioneering implementations of analytics to business decision making: contributions to domain knowledge conceptualization, research design, methodology development, data modeling and statistical data analysis: Aviva Lev-Ari, UCB, PhD’83; HUJI MA’76
- Recollections: Part 1 – My days at Berkeley, 9/1978 – 12/1983 – About my doctoral advisor, Allan Pred, other Professors and other Peers
- Recollections: Part 2 – “While Rolling” is preceded by “While Enrolling” Autobiographical Alumna Recollections of Berkeley – Aviva Lev-Ari, PhD’83
- Professional Self Re-Invention: From Academia to Industry – Opportunities for PhDs in the Business Sector of the Economy
- Key Opinion Leader (KOL) in Pharmaceutical Business Intelligence – Aviva Lev-Ari, PhD, RN, as evidenced by
- Data Science is the Greatest Science! It is the Greatest Science for Women, as well
About the Open Access Online Scientific Journal pharmaceuticalintelligence.com
- e-Scientific Publishing: The Competitive Advantage of a Powerhouse for Curation of Scientific Findings and Methodology Development for e-Scientific Publishing – LPBI Group, A Case in Point – Updated on 4/2/2018
List of BioTech Conferences in 2018
covered in REAL TIME by Aviva Lev-Ari, PhD, RN
2018 MassBio Annual Meeting March 21, 2017 8:00 AM – March 22, 2017 4:00 PM, Royal Sonesta Boston, Cambridge MA – Due to Snow Storm Warning I did not attend.
AI & Machine Learning in Clinical Trials, APRIL 12, 2018 PFIZER INNOVATION RESEARCH LAB – CAMBRIDGE, MA
2018 Annual World Medical Innovation Forum Artificial Intelligence April 23–25, 2018 Boston, Massachusetts | Westin Copley Place
The Convergence of Medical Devices & Drugs: Advances in Drug Delivery May 3, 2018 12:00 PM – 5:00 PM, Westin Hotel, Waltham, MA
12th Annual US-India BioPharma & Healthcare Summit, May 8, 2018, Marriott Cambridge
2018 CHI’s BioIT World conference & Expo, May 15 – 17, 2018, Boston, MA – Seaport World Trade Center
BIO 2018! June 4-7, 2018 at Boston Convention & Exhibition Center
17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM
CHI’s Discovery on Target, Sheraton Boston, Sept. 25-28, 2018
The 14th Annual Personalized Medicine Conference, November 13 – 15, 2018, Joseph B. Martin Conference Center, HARVARD MEDICAL SCHOOL, Boston
http://www.personalizedmedicinecoalition.org/Events
List of BioTech Conferences in 2013 – 2018
covered in REAL TIME by Aviva Lev-Ari, PhD, RN on Press Pass
| Year | # Conferences covered in Real Time | Conference Organizers |
| 2020 | ||
| 2019 | ||
| 2018 | 10 | MassBio, AI,ML&CL, MassBio-Devices&Drugs, WMIF-AI-Partners, US-India BioPharma, BioIT, BIO 2018!, Koch@MIT, , CHI-DiscoveryonTarget, PMC-HMS |
| 2017 | 12 | MassBio, WMIF-CVD-Partners, US-India BioPharma, BioIT, Koch@MIT, CHI-IO CHI OncoVirus IO, WarrenLecture-HMS, HubWeek, Koch@MIT, EmTech@MIT, PMC-HMS |
| 2016 | 8 | MassBio, WMIF-Cancer-Partners, US-IndiaBioPharma, CHI-IO, CHI-OncoVirus IO, CHI DiscoveryonTarget, EmTech @MIT, PMC-HMS |
| 2015 | 5 | PMWC-SiliconVallley, MassBio, BioIT, EmTech@MIT, PMC-HMS, |
| 2014 | 7 | SacksAssoc-NY, MassBio, BioIT Koch@MIT, SacksAssoc-Basel, Brandeis, PMC-HMS, |
| 2013 | 1 | BioIT |
- Tweets Impression Analytics, Re-Tweets, Tweets and Likes by @AVIVA1950 and @pharma_BI for 2018 BioIT, Boston, 5/15 – 5/17, 2018
- 12th Annual US-India BioPharma & Healthcare Summit, May 8, 2018, Marriott Cambridge
- Synopsis Day 1: 2018 Annual World Medical Innovation Forum Artificial Intelligence April 23–25, 2018 Boston, Massachusetts | Westin Copley Place
- Synopsis Day 2: 2018 Annual World Medical Innovation Forum Artificial Intelligence April 23–25, 2018 Boston, Massachusetts | Westin Copley Place
- Synopsis Day 3: 2018 Annual World Medical Innovation Forum Artificial Intelligence April 23–25, 2018 Boston, Massachusetts | Westin Copley Place
- Synopsis for AI & Machine Learning in Clinical Trials, APRIL 12, 2018 PFIZER INNOVATION RESEARCH LAB – CAMBRIDGE, MA
- Tweets for AI and Machine Learning in Clinical Trials April 12th, 2018 hosted at Pfizer’s Innovation Research Lab in Cambridge, MA @AVIVA1950 @pharma_BI
3/31/2018
Aviva Lev-Ari, PhD, RN was nominated for the 2018 XXXXXX Prize for contributions to YYYYYYY Development
List of Conferences to be attended and covered in Real Time in 2018, includes the following Conferences:
- AI & Machine Learning in Clinical Trials, APRIL 12, 2018 PFIZER INNOVATION RESEARCH LAB – CAMBRIDGE, MA
- 2018 Annual World Medical Innovation Forum Artificial Intelligence April 23–25, 2018 Boston, Massachusetts | Westin Copley Place
- The Convergence of Medical Devices & Drugs: Advances in Drug Delivery May 3, 2018 12:00 PM – 5:00 PM, Westin Hotel, Waltham, MA
- 12th Annual US-India BioPharma & Healthcare Summit, May 8, 2018, Marriott Cambridge
- 2018 CHI’s BioIT World conference & Expo, May 15 – 17, 2018, Boston, MA – Seaport World Trade Center
- CHI’s Discovery on Target, Sheraton Boston, Sept. 25-28, 2018
- The 14th Annual Personalized Medicine Conference, November 13 – 15, 2018, Joseph B. Martin Conference Center, HARVARD MEDICAL SCHOOL, Boston
http://www.personalizedmedicinecoalition.org/Events
2017
12/30/2017
Volume Four: Medical 3D BioPrinting – The Revolution in Medicine, Technologies for Patient-centered Medicine: From R&D in Biologics to New Medical Devices
Editors: Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
Available on Kindle Store @ Amazon.com since 12/30/2017
https://www.amazon.com/dp/B078QVDV2W
List of Contributors
1.1, 1.2, 1.3, 1.4, 1.5, 1.7, 1.9, 2.3, 3.3, 3.10, 4.1, 4.2, 4.3, 4.8, 5.4, 7.1, 7.2, 7.3, 7.4, 7.5, 7.9, 7.10, 8.1, 8.2, 8.5, 9.1, 12.1, 12.2, 12.3, 12.8, 13.6
1.8, 1.14, 2.1, 2.2, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 2.10, 2.11, 3.1, 3.2, 3.4, 3.6, 3.7, 3.8, 3.9, 3.10, 4.10, 4.17, 5.2, 5.3, 6.3, 6.4, 6.5, 6.6, 6.11, 7.1, 7.6, 7.7, 8.2, 9.2, 9.3, 9.4, 9.6, 10.1, 10.2, 10.3, 11.4, 11.5, 12.5, 13.1, 13.4, 13.7
1.6, 1.12, 1.12.1, 1.12.2, 1.13.1, 1.15, 1.16, 4.4, 4.4.1, 4.5, 4.6, 4.9.1, 4.11, 4.12, 4.14, 4.14.1, 4.15, 4.16, 5.1, 5.5, 6.9, 6.12, 6.13, 7.8, 8.3, 8.4, 9.7, 9.8, 10.4, 12.1.1, 12.1.2, 12.4, 12.8.1, 12.8.2, 12.8.3, 12.9, 12.10, 13.3, 13.5
1.10, 6.1, 6.2, 6.7, 6.10, 12.7, 13.2
1.11, 4.7, 4.9, 6.8, 9.5, 10.5, 11.1, 11.6
1.13
3.5, 4.13
5.2, 9.3, 11.3
11.2
12.6
Gail S. Thornton, M.A., PhD(c)
4.18, 4.19
12/20/2017
LPBI Group Accomplishments 4/2012 – 12/2017 for Open Access Online Scientific Journal
http://pharmaceuticalintelligence.com
1,354,866 e-Readers
7,282 Scientific Comments
5,231 Scientific Articles,
610 Research Categories in Medicine and Life Sciences
9,719 Tags
2,284 Subscribers
Accomplishments 4/2012 – 12/2017 for BioMed e-Series
https://pharmaceuticalintelligence.com/biomed-e-books/
electronic Table of Contents (eTOCs) of each Volume in the SIXTEEN Volume BioMed e-Series
https://pharmaceuticalintelligence.com/2017/12/12/biomed-e-series-16-volumes-electronic-table-of-contents-of-each-volume/
WE ARE ON AMAZON.COM
https://www.amazon.com/s/ref=nb_sb_noss?url=search-alias%3Ddigital-text&field-keywords=Aviva+Lev-Ari&rh=n%3A133140011%2Ck%3AAviva+Lev-Ari
http://www.amazon.com/dp/B00DINFFYC
http://www.amazon.com/dp/B018Q5MCN8
http://www.amazon.com/dp/B018PNHJ84
http://www.amazon.com/dp/B018DHBUO6
http://www.amazon.com/dp/B013RVYR2K
http://www.amazon.com/dp/B012BB0ZF0
http://www.amazon.com/dp/B019UM909A
http://www.amazon.com/dp/B019VH97LU
http://www.amazon.com/dp/B071VQ6YYK
https://www.amazon.com/dp/B075CXHY1B
https://www.amazon.com/dp/B076HGB6MZ
https://www.amazon.com/dp/B078313281
11/17/2017
- Tweets by @pharma_BI and @AVIVA1950 for #PMConf at The 13th Annual Personalized Medicine Conference, From Concept to the Clinic, November 14–16, 2017, Joseph B. Martin Conference Center, Harvard Medical School
- Day 1 – 13th Annual Personalized Medicine Conference, From Concept to the Clinic, November 14–16, 2017
- Day 2 – 13th Annual Personalized Medicine Conference, From Concept to the Clinic, November 14–16, 2017
11/9/2017
Mr. Sweeney,
Thank you for having me as MEDIA on this OUTSTANDING event – 2017 EmTechMIT
- LIVE Day Two and Day One – 17th Annual EmTech @ Media Lab, MIT – November 7 – 8, 2017, Cambridge, MA – This Year’s Themes, Speakers and Agenda
- All my Tweets for 11/7 and 11/8 at @AVIVA1950
- #EmTechMIT – only some are featured , not all – Why?
- All my Tweets for 11/7 and 11/8 at @pharma_BI
Kind regards,
Aviva Lev-Ari, PhD, RN
Director & Founder
Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston
Editor-in-Chief
http://pharmaceuticalintelligence.com
e-Mail: avivalev-ari@alum.berkeley.edu
https://cal.berkeley.edu/AvivaLev-Ari,PhD,RN
SkypeID: HarpPlayer83 LinkedIn Profile Twitter Profile
10/24/2017
Koch Institute Immune Engineering Symposium on October 16 & 17, 2017, Kresge, MIT
LIVE HubWeek – Harvard, MIT, MGH, Boston multiple locations, 10/10 – 10/15, 2017
Lectures by The 2017 Award Recipients of Warren Alpert Foundation Prize in Cancer Immunology, October 5, 2017, HMS, 77 Louis Paster, Boston
10/16/2017
Series E: Patient-centered Medicine
Content Consultant: Larry H Bernstein, MD, FCAP
Volume 1: The VOICES of Patients, Hospitals CEOs, Health Care Providers, Caregivers and Families: Personal Experience with Critical Care and Invasive Medical Procedures
Author, Curator and Editor: Larry H Bernstein, MD, FCAP and Gail Thornston, PhD(c)
On Amazon.com since 10/16/2017
https://www.amazon.com/dp/B076HGB6MZ
9/8/2017
List of LIVE Press Coverage of BioTech Conferences in 2017
The 13th Annual Personalized Medicine Conference, NOVEMBER 14 – 16, 2017, Joseph B. Martin Conference Center, HARVARD MEDICAL SCHOOL, Boston
17th Annual EmTech @ Media Lab, MIT – November 7 – 8, 2017, Cambridge, MA – This Year’s Themes, Speakers and Agenda
Koch Institute Immune Engineering Symposium on October 16 & 17, 2017, Kresge, MIT
Lectures by The 2017 Award Recipients of Warren Alpert Foundation Prize in Cancer Immunology, October 5, 2017, HMS, 77 Louis Paster, Boston
CHI’s Oncolytic Virus Immunotherapy and ADOPTIVE CELL THERAPY, August 28-29, 2017 Sheraton Boston Hotel | Boston, MA
CHI’s 5th Immune Oncology Summit – CHI’s 4th Oncolytic Virus Immunotherapy, August 28-29, 2017 Sheraton Boston Hotel | Boston, MA
16th Annual Cancer Research Symposium, Koch Institute, Friday, June 16, 2017, 9AM – 5PM, Kresge Auditorium, MIT
BioInformatics: Track 6: BioIT World Conference & Expo ’17, May 23-25, 2017, Seaport World Trade Center, Boston, MA – On an Unplanned Overseas Trip
11th US-India BioPharma & Healthcare Summit, Thursday, May 18, 2017, Boston Marriott Cambridge, 50 Broadway, Cambridge
2017 World Medical Innovation Forum: Cardiovascular, May 1-3, 2017, Partners HealthCare, Boston, at the Westin Hotel, Boston
2017 MassBio Annual Meeting March 30, 2017 8:00 AM – March 31, 2017 4:00 PM, Royal Sonesta Boston, Cambridge MA
9/6/2017
MON, September 4, 2017 we published on Amazon.com
The Immune System, Stress Signaling, Infectious Diseases and Therapeutic Implications: VOLUME 2: Infectious Diseases and Therapeutics and VOLUME 3: The Immune System and Therapeutics (Series D: BioMedicine & Immunology) Kindle Edition
by Larry H. Bernstein (Author), Aviva Lev-Ari (Author), Stephen J. Williams (Author), Demet Sag (Author), Irina Robu (Author), Tilda Barliya (Author), David Orchard-Webb (Author), Alan F. Kaul (Author), Danut Dragoi (Author), Sudipta Saha (Editor)
https://www.amazon.com/dp/B075CXHY1B
MON, June 2017 – Aviva presented to Number 1 in the Scientific Publishing Corporation
Resources used included the following:
5/18/2017
OUR NEW CANCER e-Book on Amazon.com
Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery (Series C Book 2) – Kindle edition, on Amazon since 5/18/2017
Our 9th e-Book on CANCER, 2800 pages – is LIVE on Amazon.com – first day, 5/18/2017
https://www.amazon.com/dp/B071VQ6YYK
See all ours other 8 e-Books in Medicine on Amazon.com
WE ARE ON AMAZON.COM
5/5/2017
-
World Medical Innovation Forum – CARDIOVASCULAR • MAY 1-3, 2017, BOSTON, MA
(a) Real Time Highlights and Tweets: Day 1,2,3: World Medical Innovation Forum – CARDIOVASCULAR • MAY 1-3, 2017, BOSTON, MA
(b) e-Proceedings for Day 1,2,3: World Medical Innovation Forum – CARDIOVASCULAR • MAY 1-3, 2017, BOSTON, MA
(c) Tweets by @pharma_BI and @AVIVA1950 at World Medical Innovation Forum – CARDIOVASCULAR • MAY 1-3, 2017, BOSTON, MA
4/1/2017
e-Books in Medicine
- Larry Mulligan, PhD has joined LPBI Group as Co-Editor for Series A, Volume 5 [may be Volume 6??]
- Dr. Justin Pearlman, MD, PhD is working as Editor for a FOUR Volume Hard Copy Series in Cardiology
- Gail Thornton, MSc, PhD(c), Co-Editor for Series E, Volume 1 – is bringing to completion this volume
- Marzan Khan, BSc, Research Associate and Translator for Series E, Volume 2 – is in midst of volume Format conversion [may be Series e, Volume 4??]
- Tilda Barlyia, PhD, Senior Editor of Series C, Cancer, Volume 2 – completed proof reading the entire 3,000 page Volume following Format conversion by Kelly Perlman. This volume is scheduled for upload to Amazon.com on the first week in April 2017.
- Seeking Co-Editor for Genomics, Volume Two
- Series D: Biomedicine:
VOLUME 1,
- Metabolic Genomics and Pharmaceutics, on Amazon since 7/21/2015
http://www.amazon.com/dp/B012BB0ZF0
VOLUME 2,
- Infectious Diseases and Therapeutics
Author, Curator and Editor: Sudipta Saha, PhD
VOLUME 3,
- The Immune System and Therapeutics
Author, Curator and Editor: Larry H Bernstein, MD, FCAP
3/13/2017
List of BioTech Conferences we cover in Real Time in 2017
The 13th Annual Personalized Medicine Conference, NOVEMBER 14 – 16, 2017, Joseph B. Martin Conference Center, HARVARD MEDICAL SCHOOL, Boston
16th Annual Cancer Research Symposium, Koch Institute, Friday, June 16, 2017, 9AM – 5PM, Kresge Auditorium, MIT
BioInformatics: Track 6: BioIT World Conference & Expo ’17, May 23-25, 2017, Seaport World Trade Center, Boston, MA
2017 World Medical Innovation Forum: Cardiovascular, May 1-3, 2017, Partners HealthCare, Boston, at the Westin Hotel, Boston
2017 MassBio Annual Meeting March 30, 2017 8:00 AM – March 31, 2017 4:00 PM, Royal Sonesta Boston, Cambridge MA
1/23/2017
e-Books in Medicine
- Larry Mulligan, PhD has joined LPBI Group as Co-Editor for Series A, Volume 5 [may be Volume 6??]
- Dr. Justin Pearlman, MD, PhD is working as Editor for a FOUR Volume Hard Copy Series in Cardiology
- Gail Thornton, MSc, PhD(c), Co-Editor for Series E, Volume 1 – is bringing to completion this volume
- Marzan Khan, BSc, Research Associate and Translator for Series E, Volume 2 – is in midst of volume Format conversion [may be Series e, Volume 4??]
- Tilda Barlyia, PhD, Senior Editor of Series C, Cancer, Volume 2 – is proof reading the entire 3,000 page Volume following Format conversion by Kelly Perlman
- Seeking Co-Editor for Genomics Volume 2
DrugDiscovery & DrugDelivery @LPBI Group
- Our Team – DrugDiscovery @LPBI Group, is developing a new Mechanism of Action for Panceatic Cancer and Several other Cancers honing hybrid exosome-lysosome technology for an Oncolytic Viral Therapeutics solution
Aviva Lev-Ari, PhD, RN
https://pharmaceuticalintelligence.com/contributors-biographies/aviva-lev-ari/
Dr. Raphael Nir – Drug Discovery: Expertise in Cancer
Dr. David Orchard-Webb – Drug Discovery: Expertise in Pancreatic Cancer
Dr. Irina Robu – Drug Delivery – Expertise in Nanotechnology, Polymers, Hybridization: Liposome, Exosome, Lysosome
Dr. Aashir Awan – Drug Discovery: Expertise in Salivary Adenoid Cystic Carcinoma and cilia: motile cilia and nonmotile, or primary cilia, which typically serve as sensory organelles, In vivo and In vitro wet lab studies
Dr. Tilda Barlyia – Scientific Consultant to Aviva and to Our Team: DrugDiscovery @LPBI Group
Expertise in Molecular Biology, Cancer, Nanotechnology, Ophthalmology
Ms. Marzan Khan – Lab Biochemistry and Physics
Funding Early Stage Start Ups
a. We will continue to develop the concepts of mutual interest between
- A company on the West Coast
- Dr. Nir of ABI-LAB, SBH Sciences, Inc., SBH Diagnostics, Inc.
and
- Our Team – DrugDiscovery @LPBI Group:
b. Aviva, Alpha Senzsor, Inc. and an Investor are exploring two industries in France
c. Aviva and WJ, an Investor are exploring opportunities in the US, UK
d. Aviva and Arie Berger and Maggie You are exploring opportunities in China
1/7/2017
OPPORTUNITIES for Business Development EXEC – BioTech, Medical Devices, Publishing – CONTACT: avivalev-ari@alum.berkeley.edu
— BD to Sell the e-Scientific Journal to a European or Japanese Scientific Publisher
— BD to Sell the BioMed e-Series of 15 e-Books in Medicine to a European or Japanese Scientific Publisher
— BD to Sell the Methodology to a European or Japanese International Biotech Conference Organizer.
— BD to develop markets for several US Patent Holder for Licensing and Commercialize the technologies: Biologics and Medical Devices Patents
— BD to develop a Market for an e-Book on 3D BioPrinting
— BD to PROSPECT for FUNDING or M&A with existing Biotech in Biologics: Drug Discovery
— BD to develop FUNDING for 13 Ventures in Early Stage Biotech Start Ups: MEDICAL DEVICES & Biologics
2016
12/26/2016
Year End 2016 Statement on Yearly Progress by LPBI Group
Curator: Aviva Lev-Ari, PhD, RN
LPBI Group has Three Enterprise Types and Five Subsidiaries as described, below.
Image Source: Google Images
We are in Knowledge-based Informational Services
Line-of-Business #1:
Open Access OnLine Scientific Journal
- 1,121,301 e-Readers, Site Statistics on 12/26/2016
June 19, 2016 – We Celebrate reaching over One Million e-Readers @PharmaceuticalIntelligence.com
Editor-in-Chief: Aviva Lev-Ari, PhD, RN
- 5,005 Scientific Articles, Site Statistics on 12/26/2016
We Celebrate 5,000 Scientific Articles @pharmaceuticalintelligence.com – 2016 was a GREAT Year !!!!!
Curator and Open Access Journal Editor-in-Chief: Aviva Lev-Ari, PhD, RN
Curator: Aviva Lev-Ari, PhD, RN
- 7,267 Comments by Scientists, Site Statistics on 12/26/2016
- 2,183 Subscribers, Site Statistics on 12/26/2016
Line-of-Business #2:
BioMed e-Series, Five Series in Medicine, 8 e-Books on Amazon.com, 7 e-Books in 2017
Editor-in-Chief, Aviva Lev-Ari, PhD, RN
Line-of-Business #3:
Real Time Press Coverage of BioTech Global Premier Conferences, Portfolio of ~30 events
Curator: Aviva Lev-Ari, PhD, RN
Line-of-Business #4: No Progress in 2016
Audio-Podcast Series in Medicine, 5 tracks
&
-
Subsidiary 4: Intellectual Property Asset Management
Line-of-Business #5: New Patents issued to Bill Zurn
Representation of US Patent Holders for Commercialization, Licensing and Partnerships
We are in Research Biotech Businesses
-
Subsidiary 3: R&D in 3D BioPrinting
Line-of-Business #6:
Tissue Engineering, Gene Therapy: Stem Cells & Gene Editing, Medical Devices: Product Concepts
Curator: Aviva Lev-Ari, PhD, RN
Technologies for Patient-centered Medicine: From R&D in Biologics to New Medical Devices
&
-
Subsidiary 5: Pharmaceutical R&D: Drug Discovery and Drug-Devices Development
Line-of-Business #7:
Team developing new mechanism of action for Therapeutics and Diagnostics for Early Detection of Pancreatic Cancer
Line-of-Business #8:
Team developing solutions with Nanoparticles and with Exosomes
We are in Business Financial Transactions (No Securities Traded)
-
Subsidiary 2: Funding Early Stage Businesses, IP Licensing and Business Partnerships:
Line-of-Business #9:
MEDICAL DEVICES
Pharmaceutical Informational PLATFORMS
INVENTIONS IN BIOLOGICS
Representation of 13 ventures for the purpose of prospecting for funding. Seeking business partner to developing FUNDING of the following Ventures, if interested to further explore jointly, please e-mail me:
avivalev-ari@alum.berkeley.edu
-
LPBI Group’s Portfolio of Clients include the following:
- Woodland Pharmaceutical
https://gust.com/companies/woodland_pharmaceuticals
- BioTerm Pharmaceuticals
- Akshaya Bio Inc. – Portfolio of 28 Patents in vaccine – viral infection
- com
http://www.valvecure.com/Home.html
- Alpha Sensors, Inc.
- AlphaIP, Inc.
- SBH Sciences, Inc
- Telerescue
- New Medicine, Inc.
- LPBI Group – Aviva Lev-Ari, PhD, RN – Founder
10a. DrugDiscovery @LPBI Group – Aviva Lev-Ari, PhD, RN – Co–Founder and Raphael Nir, PhD – Co–Founder
https://pharmaceuticalintelligence.com/drugdiscovery-lpbi-group/
- Portfolio of Patents of S.Y. in Anti-Inflammatory, A Macro Molecule of a Multifunctional NSAID – Portfolio of 13 US Patents
- Portfolio of Patents under management of Y. M.
- Vyriad – Oncolytic Virotherapy for the Treatment of Cancer
Vyriad – http://www.vyriad.com/
12/19/2016
We Celebrate 5,000 Scientific Articles @pharmaceuticalintelligence.com – 2016 was a GREAT Year !!!!!
12/15/2016
Super RECORD of REAL TIME Coverage of Biotech and Medicine Conferences by LPBI Group in 2016
Curator: Aviva Lev-Ari, PhD, RN
2017 World Medical Innovation Forum: Cardiovascular, May 1-3, 2017, Partners HealthCare, Boston, at the Westin Hotel, Boston
Reporter: Aviva Lev-Ari, PhD, RN
ANNOUNCEMENT
Leaders in Pharmaceutical Business Intelligence (LPBI) Group will cover the event in REAL TIME
Aviva Lev-Ari, PhD, RN will be streaming live from the floor of the Westin Hotel in Boston on May 1-3, 2017
9/22/2016
Updated Business Synopsis
In 4/2012, Aviva Lev-Ari, PhD, RN has launched LPBI Group. She is an Executive-Entrepreneur with high energy and passion. Followed by 6200 Biotech professionals on LinkedIn, Group Manager of three Groups on LinkedIn in (1) Pharmaceutical Intelligence, (2) Cardiovascular Disease and (3) Innovations in Israel. Her business acumen is at the intersection of (a) electronic Scientific Media, (b) Drug Discovery and (c) Venture Funding.
LPBI Group is an early stage start up in three domains:
(1) Knowledge-based Informational Services
Open Access OnLine Scientific Journal The Site Statistics on 9/14/2016: (1,053,618 e-Readers, 2,142 Subscribers, 4,892 Scientific Articles, ~8000 Comments by Scientists)
BioMed e-Series, Five Series in Medicine, 8 e-Books on Amazon.com, 4 e-Books in 2016 and 3 e-Books in 2017
Real Time Press Coverage of BioTech Global Premier Conferences, Portfolio of ~30 events have been covered in the last 3 years. In 2016, Dr. Lev-Ari has launched an
Audio-Podcast Series in Medicine, 5 tracks.
Representation of US Patent Holders for Commercialization, Licensing and Partnerships
(2) Dr. Lev-Ari guides a Team of Scientists in Drug Discovery & Drug Delivery Research
- Drug Discovery with 3D BioPrinting
- Drug Delivery System – One solution for many agents for many indications
(3) As a Key Opinion Leader (KOL) Dr. Lev-Ari and her Team are involved in Business Financial Transactions (No Securities Traded)
· Funding Early Stage Ventures and Businesses, IP Licensing and Business Partnerships for MEDICAL DEVICES, Pharmaceutical Informational PLATFORMS and INVENTIONS IN BIOLOGICS.
9/1/2016
- Oncolytic Virus Immunotherapy Unlocking Oncolytic Virotherapies: From Science to Commercialization CHI’S 4TH ANNUAL IMMUNO-ONCOLOGY SUMMIT – AUGUST 29-30, 2016 | Marriott Long Wharf Hotel – Boston, MAhttps://pharmaceuticalintelligence.com/2016/07/15/agenda-for-oncolytic-virus-immunotherapy-unlocking-oncolytic-virotherapies-from-science-to-commercialization-chis-4th-annual-immuno-oncology-summit-august-29-30-2016-marriott-lo/
Real Time Coverage and eProceedings of Presentations on August 29 and August 30, 2016 CHI’s 4th IMMUNO-ONCOLOGY SUMMIT – Oncolytic Virus Immunotherapy Track
LIVE Tweets via @pharma_BI and by @AVIVA1950 for August 29 and August 30, 2016 of CHI’s 4th IMMUNO-ONCOLOGY SUMMIT – Oncolytic Virus Immunotherapy Track, Marriott Long Wharf Hotel – Boston
7/14/2016
ANNOUNCEMENT
Leaders in Pharmaceutical Business intelligence will cover in Real Time using Social Media
The CHI’S 4TH ANNUAL IMMUNO-ONCOLOGY SUMMIT – Personalized Immunotherapy
Personalized Oncology in the Genomic Era: Expanding the Druggable Space
http://www.immuno-oncologysummit.com/
Aviva Lev-Ari, PhD, RN
will be streaming LIVE from the Marriott Long Wharf Hotel in Boston, MA
6/8/2016
- We added a Potential Scientific Partner to DrugDiscovery @LPBI Group
- We added a New Candiddate for Funding Biologics Translational Research @LPBI Group
- Akshaya Bio, Inc.: Chimigen® Technology – Rajan George, PhD, President and CSO
Re-educating Immune System to Fight Diseases
- Unique technology platform
- Improved antigen presentation
- – “Mimics Body’s Own Natural Immune Response Process”
- – No adjuvant, avoids adverse reactions
- Rich product pipeline
– HBV, HCV, HIV, Cancer, Malaria, Biodefense, Influenza, TB, Ebola
6/2/2016
Electronic Proceedings for 10th US-India BioPharma & Healthcare Summit, June 2, 2016, Marriott Cambridge, MA
Curator: Aviva Lev-Ari, PhD, RN
LIVE Tweets via @pharma_BI and by @AVIVA1950 for 10th US-India BioPharma & Healthcare Summit, June 2, 2016, Marriott Cambridge, MA
Curator: Aviva Lev-Ari, PhD, RN
5/24/2017
10th US-India BioPharma & Healthcare Summit, Thursday, June 2, 2016, Marriott Cambridge, MA
5/17/2016
LPBI Group will cover in Real Time The 16th annual EmTech MIT – A Place of Inspiration, October 18-20, 2016, Cambridge, MA
5/17/2016
We have progress made
1. We diversified – now we handle 9 types of businesses
https://pharmaceuticalintelligence.com/drugdiscovery-lpbi-group/
2. We are Co-Partnering with CHI, the largest Life Sciences Conferences organizers in the US on the following event:
3. Commercialization of US Patents
- I was awarded representation from YISSUM, HUJI’s Technology Transfer Office, Prof. Saul Yedgar’s –13 US patents
- I will represent 26 +2 Patents in Immunology by Dr. R. George
- I continue with new sources for funding for Early stage.
4. We branched into Drug Discovery
https://pharmaceuticalintelligence.com/drugdiscovery-lpbi-group/
5. We published EIGHT e-Books in Medicine on Amazon.com
WE ARE ON AMAZON.COM
http://www.amazon.com/dp/B00DINFFYC
http://www.amazon.com/dp/B018Q5MCN8
http://www.amazon.com/dp/B018PNHJ84
http://www.amazon.com/dp/B018DHBUO6
http://www.amazon.com/dp/B013RVYR2K
http://www.amazon.com/dp/B012BB0ZF0
http://www.amazon.com/dp/B019UM909A
http://www.amazon.com/dp/B019VH97LU
6. We are working on an e-Book on 3D BioPrinting
7. We are working on an e-Book on Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS & BioInformatics, Simulations and the Genome Ontology (Work-in-Progress)
8. We are working on an e-Book on The VOICES of Patients, HealthCare Providers, Care Givers and Families: Personal Experience with Critical Care and Invasive Medical Procedures (Work-in-Progress)
4/28/2016
we plan to attend
From: “W. Eric L. Grimson PhD ’80, MIT Chancellor for Academic Advancement” <techbfast@mit.edu>
Date: Thursday, April 28, 2016 at 10:52 AM
To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>
Subject: Technology Breakfast, June 2
Dear Aviva,
Please join me on Thursday, June 2, for our next Technology Breakfast. It will be held in the new Samberg Conference Center in the Morris and Sophie Chang Building (E52). The MIT Technology Breakfast series brings together alumni, faculty, and friends to hear distinguished members of the MIT community speak on topics at the forefront of today’s technology.
Our featured company will be Luminoso. Founded in 2010 and headquartered in Cambridge, Massachusetts, Luminoso is an artificial intelligence-based software company that applies natural language processing and machine learning technologies to data analytics. Cofounder and chief executive officer Catherine Havasi ’03, MNG ’04 and cofounder and chief technology officer Jason Alonso ’04, SM ’08 will join us.
Coffee and buffet breakfast will be available at 7:00 am. The program will begin at 8:00 am and conclude at 9:00 am. Upon request, parking will be reserved for you at the MIT Hayward Lot. To confirm your attendance, please respond by Thursday, May 26, via reply e-mail. If you have questions, feel free to contact Brenda Richard at 617.253.0022 or brendar@mit.edu.
I look forward to seeing you on June 2.
Sincerely,
W. Eric L. Grimson
Chancellor for Academic Advancement
————————————————–
EVENT DETAILS
MIT Technology Breakfast
Thursday, June 2, 2016
Samberg Conference Center, 7th floor
The Morris and Sophie Chang Building (E52)
50 Memorial Drive
Cambridge, Massachusetts
7:00 am Coffee and buffet breakfast available
8:00 am Program begins
9:00 am Program concludes
Please respond by May 26 and include your NAME, TITLE, and COMPANY as you would like this information to appear on your name badge and in the program brochure.
Kindly indicate whether you will require parking.
For the location of the MIT Samberg Conference Center, please refer to: http://whereis.mit.edu/?go=E52
For the location of the MIT Hayward Lot, please refer to: http://whereis.mit.edu/map-jpg?selection=P5&Parking=go
————————————————–
About Catherine Havasi and Jason Alonso
Catherine Havasi is a cofounder and the chief executive officer of Luminoso. Luminoso is based on nearly a decade of research at the MIT Media Lab on how natural language processing and machine learning could be applied to text analytics. Havasi also directs the Open Mind Common Sense Project, one of the largest common sense knowledge bases in the world, which she cofounded with Marvin Minsky and Push Singh in 1999. She earned an SB and an SM in electrical engineering and computer science from MIT, and a PhD in computer science from Brandeis University.
Jason Alonso is a cofounder and the chief technology officer of Luminoso. He joined the Open Mind Common Sense Project in 2006. In 2007, he cofounded and was the first CFO of Learning Unlimited, an education nonprofit with roots in the MIT Educational Studies Program. Alonso earned an SB in electrical engineering and computer science and an SM in media arts and sciences from MIT.
4/12/2016
- Announcing David Orchard-Webb, PhD joined LPBI Group as Expert, Author, Writer with expertise in Cancer Biology and “DrugDiscovery @LPBI Group” as Scientist II working on Anti-Cancer Drug Discovery: TCRL
- CHI proposal to co-Partner the CRISPR Conference in Boston,September 19-22,2016
4/5/2016
- Agreement with Yissum regarding 13 Patents of SY is on its way
- Mr. A.D. of Los Angeles will meet with Zur Technologies, CEO and with BioTerm Pharmaceutical regarding Funding Opportunities
4/4/2016
“DrugDiscovery @LPBI Group” is a Start Up in Health/Life Sciences in MA
VISIT our Web site
https://pharmaceuticalintelligence.com/drugdiscovery-lpbi-group/
The Team
Team Profile: DrugDiscovery @LPBI Group – A BioTech Start Up submitted for Funding Competition to MassChallenge Boston 2016 Accelerator
We are Applicants for MassChallenge Boston 2016 Accelerator
https://accelerate.masschallenge.org/startup/11021/team/
4/3/2016
- Announcing Contributing Editor and Author
Gail S. Thornton, PhD(c)
Series E Volume One – Sourcer for Patient Accounting on Voicing Post Invasive Interventions
4/3/2016
- I will announce Replacement to Adam Sonnenberg for the role of:
Research Associate on BioMed e-Series
– Content Digitization, e-Format Conversion and Complex Proof Reading
Debashree Chakrabarti, MSc (5/2016), Research Associate for Enterprise Technologies: E-Scientific Publishing and Drug Discovery
4/3/2016
From: MassChallenge <contact@masschallenge.org>
Reply-To: <contact@masschallenge.org>
Date: Saturday, April 2, 2016 at 3:17 PM
To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>
Subject: MC Update – Applications Close
Click to Browse the 2016 Startup Applicants
We are DrugDiscovery@LPBI Group – Boston 2016 – Health/Life Sciences
– Three Indications:
- Diabetes – A Combination Drug Therapy to induce Insulin Production by Pancreatic Beta Cells (PPAR-gamma, Leptin, ..)
- Inflammatory Disorders: Inflammatory Bowel Diseases (IBD) – Crohn’s and Ulcerative Colitis (UC) and Others
- Anti-Cancer Drug Discovery @ LPBI Group’s Research Biotech Businesses
3/28/2016
From: MassChallenge <apply@masschallenge.org>
Date: Monday, March 28, 2016 at 1:11 PM
To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>
Cc: MassChallenge <apply@masschallenge.org>
Subject: Your MassChallenge 2016 Jun-Oct Program Cycle Application for DrugDiscovery@LPBI Group has been Submitted
Hi Aviva,
Thank you for submitting your application for MassChallenge Boston 2016 Accelerator for your startup, DrugDiscovery@LPBI Group. It has been received and will be reviewed by MassChallenge judges.
Best,
The MassChallenge Team
3/24/2016
You Need a New Professional Opportunity or a Business to Manage? an Affiliation? a Bigger Challenge?
- we have a ROLE for you
——>>>>>> This is a PREP for Your 2016 Professional Renewal
Author: Aviva Lev-Ari, PhD, RN
3/23/2016
From: “Gregory Piatetsky, KDnuggets” <editor1@kdnuggets.com>
Date: Wednesday, March 23, 2016 at 1:56 PM
To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>
Subject: Re: Please run for me this to your LISTSERVE – I can promote any event of yours in reciprocity
Aviva,
I have posted your job ad on www.kdnuggets.com/news
and www.kdnuggets.com/jobs pages.
Please check
Will also share it on KDnuggets Twitter, Facebook page, LinkedIn group, Google+, and RSS , and include it in the next issue (Mar 30) of KDnuggets News email newsletter.
Gregory Piatetsky
President, KDnuggets
3/17/2016
BILL ZURN
Cardiovascular Medical Devices Inventor:
William Harrison Zurn
UPDATED on 3/17/2016
Bill Zurn is Founder and Chairman of the Board “Vascular Devices” – LLC, a start-up company chartered to develop his patented, untethered human vessel catheter.
This catheter is the world’s first untethered catheter, a fifth generation device that produces a burst of laser energy to vaporize vessel blockages.
3/2/2016
GDE Enterprises changed name to LPBI Group
2/25/2016
Published on 2/25/2016:
- PROTOCOL for GDE’s Recruiting Strategy for R&D Scientists I,II,III and R&D Project Managers for Drug Discovery: Three Indications Considered
- PROTOCOL for Drug Screening of 3rd Party Intellectual Property Presented for Funding Representation
2/23/2016
- Discussed R&D in Anti-Cancer Drug development with TB & ZR on 2/13/2016
- Discussed R&D in Anti-Cancer Drug development with DOW & RT on 2/24/2016
- Nominated Dr. Larry H. Bernstein to PMC 2016 Award on 2/18/2016
- Touched basis with our Financial Placement Agency in NYC 2/19/2016
- Secured Alpha Szenszors, Inc. Presentation for our Financial Placement Agency in NYC on 2/22/2016
- In Discussions with a Medical Devices BD
- Invited Dr. Singer for 2 days in Boston for training on Demos of BioMed Series to Dean’s of Medical Schools
- Dr. Cohn’s Paper awaits posting in the Journal
- Mr. Zurn’s Presentation, 2/18 awaits Aviva’s editing, posting in the Journal and placement in Series E, Volume 4.
- Dr. Codrington will pursue her own venture, EAW’s Status changed to Inactive, 2/19
- Dr. Cohn – on leave of absence, EAW’s Status changed to Inactive, 2/19
2/18/2016
Aviva nominate Larry H. Bernstein, MD, FCAP for 12th Annual Award for Leadership in Personalized Medicine
Letter of nomination for 12th Annual Award for Leadership in Personalized Medicine
Larry H. Bernstein, MD , FCAP
Dr. Bernstein had advanced the Personalized Medicine Paradigm in a pursuit of over 40 years of a career in Medicine.
In his own words:
My Life in Medicine: Larry H. Bernstein, M.D.
www.linkedin.com/pub/larry-h-bernstein/a/599/50
I retired from a five year position as Chief of the Division of Clinical Pathology (Laboratory Medicine) at New York Methodist Hospital-Weill Cornell Affiliate, Park Slope, Brooklyn in 2008 followed by an interim consultancy at Norwalk Hospital in 2010. I then became engaged with a medical informatics project called “Second Opinion” with Gil David and Ronald Coifman, Emeritus Professor and Chairman of the Department of Mathematics in the Program in Applied Mathematics at Yale. I went to Prof. Coifman with a large database of 30,000 hemograms that are the most commonly ordered test in medicine because of the elucidation of red cell, white cell and platelet populations in the blood. The problem boiled down to a level of noise that exists in such data, and developing a primary evidence-based classification that technology did not support until the first decade of the 21stcentury. READ MORE
In my own words:
The Young Surgeon and The Retired Pathologist: On Science, Medicine and HealthCare Policy – The Best Writers Among the WRITERS
Curator: Aviva Lev-Ari, PhD, RN
Of all the readings and reviews I completed to date, my appreciation got bonded to two Science and Medicine writers:
- a Young Surgeon, Atul Gawande, MD, MPH
and
- a Retired Pathologist, Pathophysiologist, Histologist, Bacteriologist, Chemical Geneticist, BioChemist, Enzymologist, Molecular Biologist, Mathematical Statistician and more, Larry H Bernstein, MD, FCAP
I am inviting the e-Readers to join me on a language immersion during a LITERARY TOUR in Science, Medicine and HealthCare Policy.
- Dr. Bernstein has expressed his views on Personalized Medicine in a series of articles on Predicted Cost of Care and the Affordable Care Act, Impact of 2013 HealthCare Reform in the US & Patient Protection and Affordable Care Act
- His views of advocacy for Personalized Medicine are expressed in EIGHT Books and another two in the Printing Process for 2016 publication, as follows:
2013 e-Book on Amazon.com
- Perspectives on Nitric Oxide in Disease Mechanisms, on Amazon since 6/2/12013
http://www.amazon.com/dp/B00DINFFYC
2015 e-Book on Amazon.com
- Metabolic Genomics and Pharmaceutics, on Amazon since 7/21/2015
http://www.amazon.com/dp/B012BB0ZF0
- Cancer Biology & Genomics for Disease Diagnosis, on Amazon since 8/11/2015
http://www.amazon.com/dp/B013RVYR2K
- Genomics Orientations for Personalized Medicine, on Amazon since 11/23/2015
http://www.amazon.com/dp/B018DHBUO6
- Milestones in Physiology: Discoveries in Medicine, Genomics and Therapeutics, on Amazon.com since 12/27/2015
http://www.amazon.com/dp/B019VH97LU
- Cardiovascular, Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation, on Amazon since 11/30/2015
http://www.amazon.com/dp/B018Q5MCN8
- Cardiovascular Diseases, Volume Three: Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics, on Amazon since 11/29/2015
http://www.amazon.com/dp/B018PNHJ84
- Cardiovascular Diseases, Volume Four: Regenerative and Translational Medicine: The Therapeutics Promise for Cardiovascular Diseases, on Amazon since 12/26/2015
http://www.amazon.com/dp/B019UM909A
Completed Volumes in PRINTING Process for 2016 Publication
Series C: e-Books on Cancer & Oncology
Volume 2: Cancer Therapies: Metabolic, Genomics, Interventional, Immunotherapy and Nanotechnology in Therapy Delivery
Authors, Curators and Editors:
Larry H Bernstein, MD, FCAP and Stephen J Williams, PhD
2016
Series E: Patient-Centered Medicine
Volume 2: Medical Scientific Discoveries for the 21st Century & Interviews with Scientific Leaders
Author, Curator and Editor: Larry H Bernstein, MD, FCAP
2016
Nominator for the 12th Annual Award for Leadership in Personalized Medicine:
Aviva Lev-Ari, PhD, RN
Director & Founder
Leaders in Pharmaceutical Business Intelligence, Boston
Editor-in-Chief
http://pharmaceuticalintelligence.com
Co-Founder, GDE Enterprises,
Boston, USA and Lausanne, Switzerland
e-Mail: avivalev-ari@alum.berkeley.edu
SkypeID: HarpPlayer83
2/8/2016
Submission for Category: Book
Nomination of e-Book, Series A: Cardiovascular Diseases, Volume 2, Cases in Development of Scientific Curation Methodology
2016 Communication Awards Nomination Form Result #9143807
The National Academies of Sciences, Engineering, and Medicine
2016 Communication Awards for Excellence in Reporting and Communicating Science, Medicine and Engineering
Nomination Confirmation
Thank you for submitting a nomination for the 2016 National Academies Communication Awards. Below please find the supporting materials necessary for your nomination category, as well as the address to which they should be sent.
|
Please select the category of your nomination: * |
Book |
|
Book Title: * |
Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation |
|
Publisher(s): * |
Amazon Kindle Direct |
|
Publication Date: (Please select one): * |
November 2015 |
|
Book Entry Summary (Please limit to 100 words): * |
The explosion of scientific information has created difficulties tying together disparate discoveries, ideas, and potential applications. Pharmaceutical Business Intelligence is developing an innovative methodology for Global access to Biomedical knowledge rather than traditional search. To attain this complex goal they disseminate ORIGINAL Research via Content Curation by experts using critical thinking process & interpretation over open access networks, offering better organization and visibility of critical information useful for innovations in academic, clinical, and industrial research. Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation at http://www.amazon.com/dp/B018Q5MCN8 is nominated as an example of this methodology. |
|
Are you nominating an individual or team (up to four individuals)? * |
Team |
|
Is this a self- or third-party nomination? * |
Third-Party Nomination: I am nominating someone other than myself. |
|
First Name * |
Larry H |
|
Last Name * |
Bernstein, MD, FCAP |
|
Title * |
Chief Scientific Officer |
|
Organization * |
Leaders in Pharmaceutical Business Intelligence |
|
Street Address |
54 FIRETHORN LANE |
|
City |
NORTHAMPTON |
|
State |
MA |
|
Postal Code |
01060 |
|
Country |
USA |
|
E-Mail Address * |
|
|
Phone Number * |
|
|
URL |
|
|
First Name |
AVIVA |
|
Last Name |
Lev-Ari, PhD, RN |
|
Organization |
Leaders in Pharmaceutical Business Intelligence |
|
E-Mail Address |
|
|
First Name |
Justin D. |
|
Last Name |
Pearlman, MD, PhD, FACC |
|
Organization |
Leaders in Pharmaceutical Business Intelligence |
|
E-Mail Address |
|
|
First Name * |
Stephen J. |
|
Last Name * |
Williams, PhD |
|
Title * |
Editor |
|
Organization * |
Leaders in Pharmaceutical Business Intelligence |
|
Street Address |
7373 Ridge Avenue |
|
Apt/Suite/Office |
116 |
|
City |
Philadelphia |
|
State |
PA |
|
Postal Code |
19128 |
|
Country |
USA |
|
E-Mail Address * |
|
|
Phone Number * |
|
|
URL |
2/2/2016
Nominations for 2016 National Academies Communication Awards For Excellence in Reporting and Communicating Science, Engineering, and Medicine, Keck Futures Initiative
Editor-in-Chief: Aviva Lev-Ari, PhD, RN
- LPBI’s BioMed e-Series, 15 e-Books Titles in Medicine and Life Sciences on Amazon.com
- LPBI’s Open Access Online Scientific Journal, http://pharmaceuticalintelligence.com
- LBPI’s BioMed e-Series Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation as an ezample of the innovative methodology of curation in Medicine and Science
1/27/2016
#1 Launching LPBI’s, Fourth Line of Business D.
FIVE Podcast – Audio Series in BioMed in the following Domains of Medicine and Life Sciences:
- Series #1: Dr. S. Saha – Reproductive Genomics
A Podcast – Audio Series on Reproductive Genomics, Male infertility and Research Breakthroughs in Female Genomic Endocrinology
- Series #2: Dr. SJ Williams – Genomics & Gene Therapy
A Podcast – Audio Series on Gene Editing and 3D BioPrinting
- Series #3: Dr. SJ Williams – Genomics & Cancer
A Podcast – Audio Series on Immune-Oncology Molecules in Development
- Series #4: Dr. A. Lev-Ari – the ART of e-Scientific Curation of Scientific Findings
A Podcast – Audio Series on CONTENT CREATION for Scientific Digital Media: Journal, e-Books, Biotech Conference Coverage in REAL TIME
- Series #5: Dr. I. Robu – Tissue Engineering & 3D Printing Materials
A Podcast – Audio Series on Medical 3D BioPrinting
#2 LPBI’s BioMed e-Series was Submitted, Reference #: 9076095, on 1/27/2016 to
The Keck Futures Initiative – a program of the National Academies of Sciences, Engineering, and Medicine, with the support of the W.M. Keck Foundation – will award four $20,000 prizes in 2016 to individuals or teams (up to four individuals associated with the creation of the work being nominated) who have developed creative, original works that address issues and advances in science, engineering and/or medicine for the general public. Nominations are accepted in four categories: Book; Film/Radio/TV; Magazine/Newspaper; and Online. The winners will be honored in the Fall 2016 and are expected to attend in person.
http://keckfutures.org/awards/nominate.html
https://fs22.formsite.com/naseo-ca/2016_com_award_nom/index.html
1/27/2016
I AM PROUD TO CONGRATULATE
- Larry H Bernstein, MD, FCAP
- Stephen J Williams, PhD
- Tilda Barliya, PhD
- Dror Nir, PhD
They constitute the TEAM that I nominated for The National Academies 2016 Communication Awards, Keck Futures Initiative – Nomination
- Category: Online
- Subject for Nomination: BioMed e-Series published in 2015 by Leaders in Pharmaceutical Business Intelligence
BioMed e-Series
https://pharmaceuticalintelligence.com/biomed-e-books/
- Cancer Biology & Genomics for Disease Diagnosis,
- Genomics Orientations for Personalized Medicine,
- Metabolic Genomics and Pharmaceutics,
- Milestones in Physiology: Discoveries in Medicine, Genomics and Therapeutics,
- Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics,
- Regenerative and Translational Medicine: The Therapeutics Promise for Cardiovascular Diseases
100 words
BioMed e-Series published in 2015 e-Books to popularize the Scientific findings of the frontier in Medicine and Life Sciences focusing on the top two Public HealthCare hazards: Cardiovascular Diseases and Cancer. The e-Series consists of medical interpretations of the most challenging causes of mortality and morbidities in Cancer Biology & Genomics for Disease Diagnosis, Genomics Orientations for Personalized Medicine, Metabolic Genomics and Pharmaceutics, the Milestones in Physiology: Discoveries in Medicine, Genomics and Therapeutics, the Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics. Precision Medicine as EndFragment
1/5/2016
- Accomplishments by Subsidiary #1: Scientific Media
A. The Journal
Our Realization 2014 2015 All Times Total on 1/3/2016
# e-Readers 230,000 300,000 841,700
New Articles 1,087 (+41.58%) 1,316 (+30.95%)
Total # of Articles 2,614 3,929 3,937
B. WE ARE on AMAZON.COM with EIGHT e-Books in Medicine
http://www.amazon.com/dp/B00DINFFYC
http://www.amazon.com/dp/B018Q5MCN8
http://www.amazon.com/dp/B018PNHJ84
http://www.amazon.com/dp/B018DHBUO6
http://www.amazon.com/dp/B013RVYR2K
http://www.amazon.com/dp/B012BB0ZF0
http://www.amazon.com/dp/B019UM909A
http://www.amazon.com/dp/B019VH97LU
C. Press Coverage
The 11th Annual Personalized Medicine Conference, November 18-19, 2015, Joseph B. Martin Conference Center of the Harvard New Research Building at Harvard Medical School
The 15th Annual EmTech MIT, November 2–4, 2015, MIT Media Lab, Cambridge, MA
Explores technologies highlighted in the recent 10 Breakthrough Technologies list and celebrates the 2015 Innovators Under 35.
9/17/2015 -LIVE – Real Time Coverage of Kailath Lecture and Colloquium 2015 September 17 – 19, Stanford CA – James H. Clark Center, 318 Campus Drive West, Stanford University, CA
9/18/2015 – LIVE – Real Time Coverage of Kailath Lecture and Colloquium 2015 September 17 – 19, Stanford CA – James H. Clark Center, 318 Campus Drive West, Stanford University, CA
Cambridge HealthTech Institute’s 14th Annual Meeting BioIT World – Conference & Expo ’15, April 21 – 23, 2015 @Seaport World Trade Center, Boston, MA
MassBio Annual Meeting 2015, Cambridge, MA, Sonesta Hotel, March 26 – March 27, 2015
Silicon Valley 2015 Personalized Medicine World Conference, Mountain View, CA, January 26, 2015, 8:00AM to January 28, 2015, 3:30PM PST
Subsidiary #2: Funding Early Stage Biotech: IP by others
- Dealings with Yissum — on hold
- No Progress on other ventures, yet
- Average investment needed per venture $10Million and above
Subsidiary #3: Medical 3D BioPrinting (M3DP): Team of 15
Funding needs: $20Million
8/2015 – 12/2015 – Team accomplished a 14 Presentation Series on 3D BioPrinting for
Tissue Engineering, Gene Therapy: Stem Cells and Gene Editing and Drug dosing and printing, artificial organs, MEMS and Programmable Sensors
1/2016 – 3/2016 – Team engaged in Presentations on BioMEMS
4/2016 – 6/2016 – Team engaged in Presentations on Stem Cells
- Gerard manages VARS of BioPrinters and BioInks
Subsidiary #4: U.S. and Int’l Patents
- Funding needed to commercialize,
- Partnerships to license
- Buyers for Sales of IP of Two Team members:
(a) to “corporate accounts”
(b) to “IP and Technology Patents Fund Managers
Subsidiary #5: Joint Venture: SBH & M3DP (same Team as Subsidiary #3)
Funding needs: $10 Million
- Dr. Nir and Aviva manage creation of a pipeline of Product Concepts
@@@@@@@@@
2015
12/2/2015
Please write a Book Review on Amazon.com – for ONE of our e–Books in your domain of expertise in Medicine
The entire BioMed e-Series – Sixteen Titles, is at
https://pharmaceuticalintelligence.com/biomed-e-books/
Series A: e-Books on Cardiovascular Diseases
Content Consultant: Justin D Pearlman, MD, PhD, FACC
Volume One: Perspectives on Nitric Oxide
available on Kindle Store @ Amazon.com
http://www.amazon.com/dp/B00DINFFYC
Sr. Editor: Larry Bernstein, MD, FCAP, Editor: Aviral Vatsa, PhD and Content Consultant: Stephen J Williams, PhD
Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation
available on Kindle Store @ Amazon.com
http://www.amazon.com/dp/B018Q5MCN8
Curators: Justin D Pearlman, MD, PhD, FACC, Larry H Bernstein, MD, FCAP, Aviva Lev-Ari, PhD, RN
Volume Three: Etiologies of CVD: Epigenetics, Genetics & Genomics
available on Kindle Store @ Amazon.com
http://www.amazon.com/dp/B018PNHJ84
Curators: Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
Series B: e-Books on Genomics & Medicine
Content Consultant: Larry H Bernstein, MD, FCAP
Volume One: Genomics and Personalized Medicine
available on Kindle Store @ Amazon.com
http://www.amazon.com/dp/B018DHBUO6
Sr. Editor: Stephen J Williams, PhD
Editors: Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
Series C: e-Books on Cancer & Oncology
Content Consultant: Larry H Bernstein, MD, FCAP
Volume One: Cancer and Genomics
available on Kindle Store @ Amazon.com
http://www.amazon.com/dp/B013RVYR2K
Sr. Editor: Stephen J Williams, PhD, Editors: Ritu Saxena, PhD, Tilda Barliya, PhD
Series D: e-Books on BioMedicine & Immunology
Content Consultant: Larry H Bernstein, MD, FCAP
Volume One: Metabolic Genomics & Pharmaceutics
available on Kindle Store @ Amazon.com
http://www.amazon.com/dp/B012BB0ZF0
Author, Curator and Editor: Larry H Bernstein, MD, FCAP
11/11/2015
#1. Investor Relations
1.1 CCP
Class Asset A: Funding Start Ups
Class Asset B: Funding with agreement in place
B.1 ValveCure
B.2 New Medicine, Inc.
B.3 SBH Sciences, Inc.
B.4 Woodland Pharmaceuticals
Class Asset C: US Patents and International Patents of Technology Transfer Office
Class Asset D: US Patents M3DP’s Medical Devices Inventors
D.1 Bill Zurn
D.2 Dr. Pearlman
1.2 Dr. Choppe
1.2.1 Class Asset D: US Patents M3DP’s Medical Devices Inventors
D.1 Bill Zurn
D.2 Dr. Pearlman
1.2.2 M3DP and SBH Sciences, Inc. – Joint Venture: Four Projects
We are developing a Business Plan for the Joint Venture of GDE’s Subsidiary #3: M3DP with our Business Partner for this JOINT VENTURE, DBA, SBH Sciences, Inc.
We are working on Four Projects:
Project #1:
- A Drug/Device of continuous Hormone delivery Stimulant to Insulin production for Type 1 Diabetes (Patients born with deficient Pancreas Beta Cells) and DM Type 2
A Joint Venture of the following Teams:
Technology Management: Aviva Lev-Ari, PhD, RN
Business Management: Gerard Loiseau, ESQ
SBH Sciences, Inc.
Inventor: – CEO, CSO – Dr. Rapahel Nir
and
M3DP
Inventors: Orange – US Patents Holder; Purple – UK Patent Holder
Dr. Pearlman and Bill Zurn on MEDICAL DEVICE DESIGNS
Dr. Codrington and Dr. Dragoi on Nanoparticals and magnetic fields
Dr. Codrington and Dr. Goswami on Molecular Cell Differentiation and Stem Cell Implantation
Dr. Williams, Dr. Tilda, Dr. Irina, Dr. Cohn – on biochemistry, biomechanics, pharmacodynamics and pharmacokinetics of the Drug 3D BioPrinting
Project #2:
- DIAGNOSTICS KIT for Skin Cancer using Nanotechnology
M3DP – Dr. Rosalind Codrington, Oxford, UK, Holder of two Patents issued in the UK
Project #3:
Protected: Invention: Stop MI © JDPearlman 2015
Inventor: Dr. Pearlman, US Patents Holder
Project #4:
Protected: INVENTION: 3D Reparative Transforming BioStent – Concept Description
Inventor: Dr. Pearlman, US Patents Holder
This page has the following sub pages.
2012pharmaceutical
Aashir Awan, Phd
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
amnondanzig1724
anamikasarkar
apreconasia
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
evelinacohn
Gail S Thornton
Irina Robu
jdpmd
kellyperlman
Ed Kislauskis
larryhbern
lmulligan13gmailcom
marzankhan
megbaker58
pkandala
Rosalind Codrington, PhD
ritusaxena
Rick Mandahl
sjwilliamspa
stuartlpbi
Dr. Sudipta Saha
tildabarliya
zraviv06
zs22